| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | olfactory receptor activity | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR5G3 OR7C1 OR5AU1 OR6K2 OR11H7 OR9I1 OR6Q1 OR9Q2 OR9Q1 OR6C74 OR1F2P OR13G1 OR5T2 OR6C65 OR2T11 OR1J4 OR6K6 OR1J2 OR9A1P OR1F1 OR2T3 OR51B5 OR2A12 OR6C2 OR6C4 OR2A4 OR7D2 OR51I2 OR1E1 OR7A17 OR7A10 OR9A2 OR4F6 | 1.98e-39 | 431 | 113 | 41 | GO:0004984 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR5G3 OR7C1 GPR33 OR5AU1 OR6K2 OR11H7 OR9I1 OR6Q1 OR9Q2 OR9Q1 OR6C74 OR1F2P OR13G1 OR5T2 GPR63 OR6C65 OR2T11 OR1J4 OR6K6 OR1J2 OR9A1P OR1F1 OR2T3 FZD8 OR51B5 TAS2R4 TAS2R10 OR2A12 OR6C2 ACKR3 FZD5 OR6C4 OR2A4 OR7D2 OR51I2 OR1E1 TAS2R60 OR7A17 TAS2R50 OR7A10 OR9A2 OR4F6 | 1.38e-37 | 884 | 113 | 50 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR5G3 OR7C1 GPR33 OR5AU1 OR6K2 OR11H7 OR9I1 OR6Q1 OR9Q2 OR9Q1 OR6C74 OR1F2P OR13G1 OR5T2 GPR63 OR6C65 OR2T11 OR1J4 OR6K6 OR1J2 OR9A1P OR1F1 OR2T3 FZD8 OR51B5 TAS2R4 TAS2R10 OR2A12 OR6C2 ACKR3 FZD5 OR6C4 OR2A4 OR7D2 OR51I2 SCN7A OR1E1 TAS2R60 OR7A17 TAS2R50 OR7A10 OR9A2 OR4F6 | 7.36e-30 | 1353 | 113 | 51 | GO:0004888 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SLC24A3 MCOLN1 TPCN1 SLC5A4 TRPM5 SLC24A2 SLC10A5 SCN3A SCN4A SCN5A SCN7A SCN8A SCN10A CACNA1I CACNA1H ATP1B2 SLC24A1 | 9.93e-17 | 171 | 113 | 17 | GO:0015081 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1B CACNA1S ABCC1 FLVCR1 SLC24A3 MFSD4B MCOLN1 TMC3 SLC29A2 ABCA9 ABCA8 TPCN1 SLC5A4 KCNK18 TRPM5 SLCO4C1 CATSPER2 CLCNKA CLCNKB ABCA6 SLC24A2 SLC10A5 SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A CACNA1I CACNA1H TMED10 ATP1B2 SLC24A1 | 9.81e-16 | 1180 | 113 | 34 | GO:0022857 |
| GeneOntologyMolecularFunction | sodium channel activity | MCOLN1 TPCN1 TRPM5 SCN3A SCN4A SCN5A SCN7A SCN8A SCN10A CACNA1I CACNA1H | 5.76e-15 | 52 | 113 | 11 | GO:0005272 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1B CACNA1S SLC24A3 MCOLN1 TMC3 TPCN1 KCNK18 TRPM5 CATSPER2 CLCNKA CLCNKB SLC24A2 SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A CACNA1I CACNA1H SLC24A1 | 1.16e-14 | 459 | 113 | 22 | GO:0005216 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.24e-14 | 26 | 113 | 9 | GO:0005248 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1B CACNA1S ABCC1 FLVCR1 SLC24A3 MFSD4B MCOLN1 TMC3 SLC29A2 ABCA9 ABCA8 TPCN1 SLC5A4 KCNK18 TRPM5 SLCO4C1 CATSPER2 CLCNKA CLCNKB ABCA6 SLC24A2 SLC10A5 SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A CACNA1I CACNA1H TMED10 ATP1B2 SLC24A1 | 1.32e-14 | 1289 | 113 | 34 | GO:0005215 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1B CACNA1S SLC24A3 MCOLN1 TPCN1 SLC5A4 KCNK18 TRPM5 CATSPER2 SLC24A2 SLC10A5 SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A CACNA1I CACNA1H ATP1B2 SLC24A1 | 1.52e-14 | 465 | 113 | 22 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1B CACNA1S SLC24A3 MCOLN1 TPCN1 KCNK18 TRPM5 CATSPER2 SLC24A2 SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A CACNA1I CACNA1H SLC24A1 | 6.91e-14 | 343 | 113 | 19 | GO:0005261 |
| GeneOntologyMolecularFunction | channel activity | CACNA1B CACNA1S SLC24A3 MCOLN1 TMC3 TPCN1 KCNK18 TRPM5 CATSPER2 CLCNKA CLCNKB SLC24A2 SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A CACNA1I CACNA1H SLC24A1 | 1.78e-13 | 525 | 113 | 22 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1B CACNA1S SLC24A3 MCOLN1 TMC3 TPCN1 KCNK18 TRPM5 CATSPER2 CLCNKA CLCNKB SLC24A2 SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A CACNA1I CACNA1H SLC24A1 | 1.84e-13 | 526 | 113 | 22 | GO:0022803 |
| GeneOntologyMolecularFunction | odorant binding | OR8I2 OR2A7 OR6N2 OR5G3 OR5AU1 OR6K2 OR9I1 OR9Q2 OR9Q1 OR13G1 OR5T2 OR6K6 OR2A4 | 3.34e-13 | 127 | 113 | 13 | GO:0005549 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1B CACNA1S ABCC1 SLC24A3 MCOLN1 TPCN1 SLC5A4 KCNK18 TRPM5 CATSPER2 CLCNKA CLCNKB SLC24A2 SLC10A5 SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A CACNA1I CACNA1H ATP1B2 SLC24A1 | 6.78e-13 | 758 | 113 | 25 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1B CACNA1S SLC24A3 MCOLN1 TMC3 TPCN1 SLC5A4 KCNK18 TRPM5 CATSPER2 CLCNKA CLCNKB SLC24A2 SLC10A5 SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A CACNA1I CACNA1H ATP1B2 SLC24A1 | 1.83e-12 | 793 | 113 | 25 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1B CACNA1S SLC24A3 MCOLN1 TPCN1 SLC5A4 KCNK18 TRPM5 CATSPER2 SLC24A2 SLC10A5 SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A CACNA1I CACNA1H ATP1B2 SLC24A1 | 6.02e-12 | 627 | 113 | 22 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1B CACNA1S SLC24A3 MCOLN1 TPCN1 SLC5A4 KCNK18 TRPM5 CATSPER2 SLC24A2 SLC10A5 SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A CACNA1I CACNA1H ATP1B2 SLC24A1 | 1.84e-11 | 664 | 113 | 22 | GO:0008324 |
| GeneOntologyMolecularFunction | calcium channel activity | CACNA1B CACNA1S SLC24A3 MCOLN1 TPCN1 TRPM5 CATSPER2 SLC24A2 CACNA1I CACNA1H SLC24A1 | 1.77e-10 | 129 | 113 | 11 | GO:0005262 |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1B CACNA1S MCOLN1 TMC3 TPCN1 KCNK18 TRPM5 CATSPER2 CLCNKA CLCNKB SCN7A KCNK10 SCN10A CACNA1I CACNA1H | 6.77e-10 | 334 | 113 | 15 | GO:0022836 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | CACNA1B CACNA1S SLC24A3 MCOLN1 TPCN1 TRPM5 CATSPER2 SLC24A2 CACNA1I CACNA1H SLC24A1 | 9.62e-10 | 151 | 113 | 11 | GO:0015085 |
| GeneOntologyMolecularFunction | voltage-gated channel activity | CACNA1B CACNA1S TPCN1 KCNK18 CATSPER2 CLCNKA CLCNKB KCNK10 SCN10A CACNA1I CACNA1H | 7.75e-09 | 184 | 113 | 11 | GO:0022832 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | CACNA1B CACNA1S KCNK18 CATSPER2 CLCNKA CLCNKB KCNK10 SCN10A CACNA1I CACNA1H | 8.52e-08 | 182 | 113 | 10 | GO:0005244 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 9.32e-07 | 14 | 113 | 4 | GO:0008331 | |
| GeneOntologyMolecularFunction | calcium, potassium:sodium antiporter activity | 1.75e-06 | 5 | 113 | 3 | GO:0008273 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 4.92e-06 | 167 | 113 | 8 | GO:0015079 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 6.05e-06 | 46 | 113 | 5 | GO:0005245 | |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 1.54e-05 | 27 | 113 | 4 | GO:0033038 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCC1 SLC24A3 MFSD4B ABCA9 ABCA8 SLC5A4 SLCO4C1 ABCA6 SLC24A2 SLC10A5 ATP1B2 SLC24A1 | 1.67e-05 | 477 | 113 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | calcium:sodium antiporter activity | 2.06e-05 | 10 | 113 | 3 | GO:0005432 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.54e-05 | 152 | 113 | 7 | GO:0022843 | |
| GeneOntologyMolecularFunction | taste receptor activity | 3.51e-05 | 33 | 113 | 4 | GO:0008527 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity | 4.84e-05 | 13 | 113 | 3 | GO:0015368 | |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 9.49e-05 | 3 | 113 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | intracellularly phosphatidylinositol-3,5-bisphosphate-gated monatomic cation channel activity | 9.49e-05 | 3 | 113 | 2 | GO:0097682 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 1.60e-04 | 19 | 113 | 3 | GO:0022821 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.69e-04 | 49 | 113 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | symporter activity | 2.12e-04 | 150 | 113 | 6 | GO:0015293 | |
| GeneOntologyMolecularFunction | NAADP-sensitive calcium-release channel activity | 3.14e-04 | 5 | 113 | 2 | GO:0072345 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.89e-04 | 109 | 113 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | calcium-activated cation channel activity | 4.67e-04 | 27 | 113 | 3 | GO:0005227 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity involved in cardiac muscle cell action potential | 4.69e-04 | 6 | 113 | 2 | GO:0086006 | |
| GeneOntologyMolecularFunction | monoatomic ion-gated channel activity | 7.07e-04 | 31 | 113 | 3 | GO:0022839 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 7.07e-04 | 31 | 113 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.21e-03 | 140 | 113 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.48e-03 | 296 | 113 | 7 | GO:0015291 | |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 1.69e-03 | 11 | 113 | 2 | GO:0005247 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 1.85e-03 | 43 | 113 | 3 | GO:0140828 | |
| GeneOntologyMolecularFunction | sodium ion binding | 2.76e-03 | 14 | 113 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 3.18e-03 | 15 | 113 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 3.44e-03 | 178 | 113 | 5 | GO:0015399 | |
| GeneOntologyMolecularFunction | potassium ion leak channel activity | 3.62e-03 | 16 | 113 | 2 | GO:0022841 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 4.08e-03 | 17 | 113 | 2 | GO:0042813 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 4.08e-03 | 17 | 113 | 2 | GO:0008308 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 4.58e-03 | 18 | 113 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 4.84e-03 | 193 | 113 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | narrow pore channel activity | 5.10e-03 | 19 | 113 | 2 | GO:0022842 | |
| GeneOntologyMolecularFunction | leak channel activity | 5.10e-03 | 19 | 113 | 2 | GO:0022840 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 5.17e-03 | 196 | 113 | 5 | GO:0005319 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 5.28e-03 | 197 | 113 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | potassium channel activity | 6.06e-03 | 128 | 113 | 4 | GO:0005267 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, for other substituted phosphate groups | 6.81e-03 | 22 | 113 | 2 | GO:0016780 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 7.34e-03 | 301 | 113 | 6 | GO:0022853 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 8.75e-03 | 25 | 113 | 2 | GO:0055056 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 8.75e-03 | 25 | 113 | 2 | GO:0015149 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 9.44e-03 | 26 | 113 | 2 | GO:0031420 | |
| GeneOntologyMolecularFunction | outward rectifier potassium channel activity | 1.02e-02 | 27 | 113 | 2 | GO:0015271 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 1.02e-02 | 27 | 113 | 2 | GO:0015145 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 1.17e-02 | 29 | 113 | 2 | GO:0051119 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR5G3 OR7C1 OR5AU1 OR6K2 OR11H7 OR9I1 OR6Q1 OR9Q2 OR9Q1 OR6C74 OR1F2P OR13G1 OR5T2 OR6C65 OR2T11 OR1J4 OR6K6 OR1J2 OR9A1P OR1F1 OR2T3 OR51B5 TAS2R4 TAS2R10 OR2A12 OR6C2 OR6C4 OR2A4 OR7D2 OR51I2 OR1E1 TAS2R60 OR7A17 TAS2R50 OR7A10 OR9A2 OR4F6 | 1.89e-43 | 485 | 114 | 45 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR5G3 OR7C1 OR5AU1 OR6K2 OR11H7 OR9I1 OR6Q1 OR9Q2 OR9Q1 OR6C74 OR1F2P OR13G1 OR5T2 OR6C65 OR2T11 OR1J4 OR6K6 OR1J2 OR9A1P OR1F1 OR2T3 OR51B5 TAS2R4 TAS2R10 OR2A12 OR6C2 OR6C4 OR2A4 OR7D2 OR51I2 OR1E1 TAS2R60 OR7A17 TAS2R50 OR7A10 OR9A2 OR4F6 | 6.32e-42 | 524 | 114 | 45 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR5G3 OR7C1 OR5AU1 OR6K2 OR11H7 OR9I1 OR6Q1 OR9Q2 OR9Q1 OR6C74 OR1F2P OR13G1 OR5T2 OR6C65 OR2T11 OR1J4 OR6K6 OR1J2 OR9A1P OR1F1 OR2T3 OR51B5 TAS2R4 TAS2R10 OR2A12 OR6C2 OR6C4 OR2A4 OR7D2 OR51I2 SCN10A OR1E1 TAS2R60 OR7A17 TAS2R50 OR7A10 OR9A2 OR4F6 | 2.88e-41 | 582 | 114 | 46 | GO:0050906 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR5G3 OR7C1 OR5AU1 OR6K2 OR11H7 OR9I1 OR6Q1 OR9Q2 OR9Q1 OR6C74 OR1F2P OR13G1 OR5T2 OR6C65 OR2T11 OR1J4 OR6K6 OR1J2 OR9A1P OR1F1 OR2T3 OR51B5 TAS2R4 TAS2R10 OR2A12 OR6C2 OR6C4 OR2A4 OR7D2 OR51I2 OR1E1 TAS2R60 OR7A17 TAS2R50 OR7A10 OR9A2 OR4F6 | 4.40e-41 | 547 | 114 | 45 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR5G3 OR7C1 OR5AU1 OR6K2 OR11H7 OR9I1 OR6Q1 OR9Q2 OR9Q1 OR6C74 OR1F2P OR13G1 OR5T2 OR6C65 OR2T11 OR1J4 OR6K6 OR1J2 OR9A1P OR1F1 OR2T3 OR51B5 OR2A12 OR6C2 OR6C4 OR2A4 OR7D2 OR51I2 OR1E1 OR7A17 OR7A10 OR9A2 OR4F6 | 9.25e-40 | 432 | 114 | 41 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR5G3 OR7C1 OR5AU1 OR6K2 OR11H7 OR9I1 OR6Q1 OR9Q2 OR9Q1 OR6C74 OR1F2P OR13G1 OR5T2 OR6C65 OR2T11 OR1J4 OR6K6 OR1J2 OR9A1P OR1F1 OR2T3 OR51B5 OR2A12 OR6C2 OR6C4 OR2A4 OR7D2 OR51I2 OR1E1 OR7A17 OR7A10 OR9A2 OR4F6 | 1.94e-38 | 465 | 114 | 41 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR5G3 OR7C1 OR5AU1 OR6K2 OR11H7 OR9I1 OR6Q1 OR9Q2 OR9Q1 CDS2 OR6C74 OR1F2P OR13G1 OR5T2 OR6C65 OR2T11 OR1J4 OR6K6 OR1J2 OR9A1P OR1F1 OR2T3 OR51B5 TAS2R4 TAS2R10 OR2A12 OR6C2 OR6C4 OR2A4 OR7D2 OR51I2 SCN10A OR1E1 TAS2R60 OR7A17 TAS2R50 OR7A10 OR9A2 OR4F6 | 2.58e-38 | 722 | 114 | 47 | GO:0051606 |
| GeneOntologyBiologicalProcess | sensory perception | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR5G3 OR7C1 OR5AU1 OR6K2 OR11H7 OR9I1 OR6Q1 OR9Q2 OR9Q1 OR6C74 OR1F2P OR13G1 OR5T2 OR6C65 OR2T11 OR1J4 OR6K6 OR1J2 OR9A1P OR1F1 OR2T3 OR51B5 TAS2R4 TAS2R10 OR2A12 OR6C2 OR6C4 OR2A4 OR7D2 OR51I2 PGAP1 SCN8A SCN10A OR1E1 TAS2R60 OR7A17 SLC24A1 TAS2R50 USH2A OR7A10 OR9A2 OR4F6 | 5.51e-34 | 1072 | 114 | 50 | GO:0007600 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR8I2 ADCY4 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR5G3 OR7C1 GPR33 OR5AU1 OR6K2 OR11H7 OR9I1 OR6Q1 OR9Q2 OR9Q1 OR6C74 OR1F2P OR13G1 OR5T2 GPR63 OR6C65 OR2T11 OR1J4 OR6K6 OR1J2 OR9A1P OR1F1 OR2T3 FZD8 DEFB4A OR51B5 TAS2R4 TAS2R10 OR2A12 OR6C2 ACKR3 FZD5 OR6C4 OR2A4 OR7D2 OR51I2 ENTPD1 OR1E1 TAS2R60 OR7A17 TAS2R50 OR7A10 OR9A2 OR4F6 | 8.09e-32 | 1395 | 114 | 53 | GO:0007186 |
| GeneOntologyBiologicalProcess | sodium ion transport | SLC24A3 MFSD4B MCOLN1 TPCN1 SLC5A4 TRPM5 CLCNKB SLC24A2 SLC10A5 SCN3A SCN4A SCN5A SCN7A SCN8A SCN10A CACNA1I CACNA1H ATP1B2 SLC24A1 | 8.26e-16 | 275 | 114 | 19 | GO:0006814 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SLC24A3 MCOLN1 TPCN1 SLC5A4 TRPM5 SLC24A2 SCN3A SCN4A SCN5A SCN7A SCN8A SCN10A CACNA1I CACNA1H ATP1B2 SLC24A1 | 3.46e-14 | 208 | 114 | 16 | GO:0035725 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1B CACNA1S ABCC1 ATP6AP1 FLVCR1 SLC24A3 MFSD4B MCOLN1 TMC3 TPCN1 SLC5A4 KCNK18 TRPM5 SLCO4C1 CATSPER2 CLCNKA CLCNKB SLC24A2 SLC10A5 SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A TSPAN13 CACNA1I CACNA1H ATP1B2 SLC24A1 | 8.65e-12 | 1374 | 114 | 31 | GO:0006811 |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1B CACNA1S FLVCR1 SLC24A3 MFSD4B MCOLN1 TPCN1 SLC5A4 KCNK18 TRPM5 CATSPER2 CLCNKB SLC24A2 SLC10A5 SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A TSPAN13 CACNA1I CACNA1H ATP1B2 SLC24A1 | 2.77e-11 | 1000 | 114 | 26 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1B CACNA1S ABCC1 ATP6AP1 SLC24A3 MCOLN1 TMC3 TPCN1 SLC5A4 KCNK18 TRPM5 CATSPER2 CLCNKA CLCNKB SLC24A2 SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A TSPAN13 CACNA1I CACNA1H ATP1B2 SLC24A1 | 5.36e-11 | 1115 | 114 | 27 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1B CACNA1S ATP6AP1 FLVCR1 SLC24A3 MFSD4B MCOLN1 TPCN1 SLC5A4 KCNK18 TRPM5 CATSPER2 CLCNKB SLC24A2 SLC10A5 SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A TSPAN13 CACNA1I CACNA1H ATP1B2 SLC24A1 | 1.23e-10 | 1157 | 114 | 27 | GO:0006812 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1B CACNA1S ATP6AP1 SLC24A3 MCOLN1 TPCN1 SLC5A4 KCNK18 TRPM5 CATSPER2 CLCNKA CLCNKB SLC24A2 SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A TSPAN13 CACNA1I CACNA1H ATP1B2 SLC24A1 | 2.33e-10 | 1017 | 114 | 25 | GO:0098660 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 9.56e-10 | 36 | 114 | 7 | GO:0086010 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1B CACNA1S ATP6AP1 SLC24A3 MCOLN1 TPCN1 SLC5A4 KCNK18 TRPM5 CATSPER2 SLC24A2 SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A TSPAN13 CACNA1I CACNA1H ATP1B2 SLC24A1 | 1.05e-09 | 922 | 114 | 23 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1B CACNA1S ATP6AP1 SLC24A3 MCOLN1 TPCN1 SLC5A4 KCNK18 TRPM5 CATSPER2 SLC24A2 SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A TSPAN13 CACNA1I CACNA1H ATP1B2 SLC24A1 | 1.58e-09 | 942 | 114 | 23 | GO:0098655 |
| GeneOntologyBiologicalProcess | neuronal action potential | 5.61e-08 | 63 | 114 | 7 | GO:0019228 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 2.54e-07 | 48 | 114 | 6 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 2.54e-07 | 48 | 114 | 6 | GO:1902656 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 8.38e-07 | 93 | 114 | 7 | GO:0086003 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.19e-06 | 62 | 114 | 6 | GO:0086002 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | CACNA1B CACNA1S SLC24A2 SCN5A CACNA1I CACNA1H ATP1B2 SLC24A1 | 1.23e-06 | 142 | 114 | 8 | GO:0099587 |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | CACNA1B CACNA1S SLC24A2 SCN5A CACNA1I CACNA1H ATP1B2 SLC24A1 | 1.23e-06 | 142 | 114 | 8 | GO:0098659 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNA1B CACNA1S SLC24A3 MCOLN1 TPCN1 TRPM5 CATSPER2 SLC24A2 TSPAN13 CACNA1I CACNA1H SLC24A1 | 1.81e-06 | 392 | 114 | 12 | GO:0070588 |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.94e-06 | 112 | 114 | 7 | GO:0019226 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 4.92e-06 | 121 | 114 | 7 | GO:0051899 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | CACNA1B CACNA1S ABCC1 SLC24A2 SCN5A CACNA1I CACNA1H ATP1B2 SLC24A1 | 5.36e-06 | 230 | 114 | 9 | GO:0098739 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 6.77e-06 | 127 | 114 | 7 | GO:0070252 | |
| GeneOntologyBiologicalProcess | heart process | CACNA1B NOX4 SCN3A SCN4A SCN5A SCN7A SCN8A SCN10A CACNA1H ATP1B2 | 8.48e-06 | 309 | 114 | 10 | GO:0003015 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 8.76e-06 | 87 | 114 | 6 | GO:0086001 | |
| GeneOntologyBiologicalProcess | action potential | 1.61e-05 | 201 | 114 | 8 | GO:0001508 | |
| GeneOntologyBiologicalProcess | calcium ion import | 1.74e-05 | 98 | 114 | 6 | GO:0070509 | |
| GeneOntologyBiologicalProcess | potassium ion transport | SLC24A3 MCOLN1 KCNK18 TRPM5 SLC24A2 SCN4A KCNK10 ATP1B2 SLC24A1 | 2.05e-05 | 272 | 114 | 9 | GO:0006813 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.28e-05 | 153 | 114 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNA1B CACNA1S SLC24A3 MCOLN1 TPCN1 TRPM5 CATSPER2 SLC24A2 TSPAN13 CACNA1I CACNA1H SLC24A1 | 2.53e-05 | 509 | 114 | 12 | GO:0006816 |
| GeneOntologyBiologicalProcess | striated muscle contraction | 2.79e-05 | 217 | 114 | 8 | GO:0006941 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 4.00e-05 | 167 | 114 | 7 | GO:0060048 | |
| GeneOntologyBiologicalProcess | heart contraction | 4.18e-05 | 298 | 114 | 9 | GO:0060047 | |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | 4.49e-05 | 232 | 114 | 8 | GO:0071805 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of bitter taste | 1.01e-04 | 44 | 114 | 4 | GO:0001580 | |
| GeneOntologyBiologicalProcess | sensory perception of bitter taste | 1.43e-04 | 48 | 114 | 4 | GO:0050913 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of taste | 1.68e-04 | 50 | 114 | 4 | GO:0050912 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 2.06e-04 | 217 | 114 | 7 | GO:0097553 | |
| GeneOntologyBiologicalProcess | circulatory system process | CACNA1B ABCC1 SLC24A3 NOX4 SLC29A2 SCN3A SCN4A SCN5A SCN7A SCN8A SCN10A CACNA1H ATP1B2 | 2.07e-04 | 733 | 114 | 13 | GO:0003013 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | KCNK18 SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A CACNA1I CACNA1H ATP1B2 | 2.72e-04 | 559 | 114 | 11 | GO:0042391 |
| GeneOntologyBiologicalProcess | sensory perception of taste | 6.13e-04 | 70 | 114 | 4 | GO:0050909 | |
| GeneOntologyBiologicalProcess | bundle of His cell action potential | 6.24e-04 | 7 | 114 | 2 | GO:0086043 | |
| GeneOntologyBiologicalProcess | bundle of His cell to Purkinje myocyte signaling | 6.24e-04 | 7 | 114 | 2 | GO:0086028 | |
| GeneOntologyBiologicalProcess | transepithelial transport | 1.20e-03 | 38 | 114 | 3 | GO:0070633 | |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell membrane depolarization | 1.32e-03 | 10 | 114 | 2 | GO:0060371 | |
| GeneOntologyBiologicalProcess | transepithelial chloride transport | 1.32e-03 | 10 | 114 | 2 | GO:0030321 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 1.38e-03 | 87 | 114 | 4 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 1.44e-03 | 88 | 114 | 4 | GO:0010232 | |
| GeneOntologyBiologicalProcess | muscle contraction | 1.72e-03 | 400 | 114 | 8 | GO:0006936 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell signaling | 1.93e-03 | 12 | 114 | 2 | GO:0086027 | |
| GeneOntologyBiologicalProcess | AV node cell action potential | 1.93e-03 | 12 | 114 | 2 | GO:0086016 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.42e-14 | 17 | 114 | 8 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 2.38e-12 | 29 | 114 | 8 | GO:0034706 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1B CACNA1S TPCN1 TRPM5 CATSPER2 CLCNKA CLCNKB SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A CACNA1I CACNA1H | 2.45e-10 | 378 | 114 | 16 | GO:0034702 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1B CACNA1S ATP6AP1 TPCN1 TRPM5 CATSPER2 CLCNKA CLCNKB SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A CACNA1I CACNA1H ATP1B2 | 4.80e-10 | 523 | 114 | 18 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | CACNA1B CACNA1S ATP6AP1 TPCN1 TRPM5 CATSPER2 CLCNKA CLCNKB SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A CACNA1I CACNA1H ATP1B2 | 1.07e-09 | 550 | 114 | 18 | GO:1990351 |
| GeneOntologyCellularComponent | cation channel complex | CACNA1B CACNA1S CATSPER2 SCN3A SCN4A SCN5A SCN7A SCN8A SCN10A CACNA1I CACNA1H | 6.68e-08 | 235 | 114 | 11 | GO:0034703 |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 5.06e-06 | 46 | 114 | 5 | GO:0005891 | |
| GeneOntologyCellularComponent | membrane protein complex | CACNA1B CACNA1S ATP6AP1 BET1L NOX4 TPCN1 FZD8 TRPM5 CATSPER2 CLCNKA CLCNKB SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A CACNA1I CACNA1H TMED10 SYVN1 ATP1B2 | 5.11e-06 | 1498 | 114 | 23 | GO:0098796 |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1B CACNA1S NOX4 FZD8 CATSPER2 SCN3A SCN4A SCN5A SCN7A SCN8A SCN10A CACNA1I CACNA1H TMED10 ATP1B2 | 2.39e-05 | 785 | 114 | 15 | GO:0098797 |
| GeneOntologyCellularComponent | calcium channel complex | 4.94e-05 | 73 | 114 | 5 | GO:0034704 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | DPAGT1 MOSPD2 ATP6AP1 OR7A5 OR7C1 OR9Q2 CDS2 ZDHHC14 NOX4 OR6K6 SC5D PGAP1 SELENOI TMED10 OR7A17 SYVN1 OR7A10 | 6.33e-04 | 1293 | 114 | 17 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | DPAGT1 MOSPD2 ATP6AP1 OR7A5 OR7C1 OR9Q2 CDS2 ZDHHC14 NOX4 OR6K6 SC5D PGAP1 SELENOI TMED10 OR7A17 SYVN1 OR7A10 | 6.66e-04 | 1299 | 114 | 17 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | DPAGT1 MOSPD2 ATP6AP1 OR7A5 OR7C1 OR9Q2 CDS2 ZDHHC14 NOX4 OR6K6 SC5D PGAP1 SELENOI TMED10 OR7A17 SYVN1 OR7A10 | 8.45e-04 | 1327 | 114 | 17 | GO:0042175 |
| HumanPheno | Hypokalemia | 2.62e-06 | 79 | 27 | 6 | HP:0002900 | |
| HumanPheno | Prolonged QT interval | 7.50e-06 | 54 | 27 | 5 | HP:0001657 | |
| HumanPheno | Abnormal QT interval | 1.74e-05 | 64 | 27 | 5 | HP:0031547 | |
| HumanPheno | Abnormal blood potassium concentration | 2.11e-05 | 113 | 27 | 6 | HP:0011042 | |
| HumanPheno | Adrenocortical abnormality | 4.31e-05 | 77 | 27 | 5 | HP:0000849 | |
| HumanPheno | Hypokalemic hypochloremic metabolic alkalosis | 8.09e-05 | 3 | 27 | 2 | HP:0004909 | |
| HumanPheno | Childhood onset | CACNA1B DPAGT1 CACNA1S ATP6AP1 FLVCR1 MCOLN1 CLCNKB PGAP1 SCN3A SCN5A SCN8A CACNA1I CACNA1H SLC24A1 | 8.61e-05 | 938 | 27 | 14 | HP:0011463 |
| HumanPheno | Abnormal urine potassium concentration | 1.03e-04 | 18 | 27 | 3 | HP:0012598 | |
| HumanPheno | Abnormal blood monovalent inorganic cation concentration | 1.21e-04 | 154 | 27 | 6 | HP:0010930 | |
| HumanPheno | Second trimester onset | 1.32e-04 | 51 | 27 | 4 | HP:0034198 | |
| HumanPheno | Reduced tendon reflexes | CACNA1B DPAGT1 CACNA1S FLVCR1 CLCNKA CLCNKB SCN3A ENTPD1 SCN4A SCN8A SCN10A | 1.57e-04 | 617 | 27 | 11 | HP:0001315 |
| HumanPheno | Hypochloremic metabolic alkalosis | 1.61e-04 | 4 | 27 | 2 | HP:0005977 | |
| HumanPheno | Reduced systolic function | 2.19e-04 | 23 | 27 | 3 | HP:0006673 | |
| HumanPheno | Abnormal urine chloride concentration | 2.68e-04 | 5 | 27 | 2 | HP:0012600 | |
| HumanPheno | Hyperchloriduria | 2.68e-04 | 5 | 27 | 2 | HP:0002914 | |
| HumanPheno | Graves disease | 2.68e-04 | 5 | 27 | 2 | HP:0100647 | |
| HumanPheno | Intellectual disability, borderline | 2.83e-04 | 25 | 27 | 3 | HP:0006889 | |
| HumanPheno | Abnormal PR interval | 2.83e-04 | 25 | 27 | 3 | HP:0031593 | |
| HumanPheno | Ventricular fibrillation | 3.01e-04 | 63 | 27 | 4 | HP:0001663 | |
| HumanPheno | Malignant hyperthermia | 3.18e-04 | 26 | 27 | 3 | HP:0002047 | |
| HumanPheno | Thyrotoxicosis with diffuse goiter | 4.01e-04 | 6 | 27 | 2 | HP:0011784 | |
| HumanPheno | Episodic hypokalemia | 4.01e-04 | 6 | 27 | 2 | HP:0012726 | |
| HumanPheno | Abnormal circulating prostaglandin circulation | 4.01e-04 | 6 | 27 | 2 | HP:0011023 | |
| HumanPheno | Decreased urinary potassium | 4.01e-04 | 6 | 27 | 2 | HP:0012364 | |
| HumanPheno | Hyperprostaglandinuria | 4.01e-04 | 6 | 27 | 2 | HP:0003527 | |
| HumanPheno | Hypomagnesemia | 5.41e-04 | 31 | 27 | 3 | HP:0002917 | |
| HumanPheno | Episodic flaccid weakness | 5.59e-04 | 7 | 27 | 2 | HP:0003752 | |
| HumanPheno | Impaired renal concentrating ability | 5.59e-04 | 7 | 27 | 2 | HP:0004727 | |
| HumanPheno | Hypochloremia | 5.59e-04 | 7 | 27 | 2 | HP:0003113 | |
| HumanPheno | Increased circulating aldosterone concentration | 5.95e-04 | 32 | 27 | 3 | HP:0000859 | |
| HumanPheno | Abnormal EKG | 6.34e-04 | 136 | 27 | 5 | HP:0003115 | |
| HumanPheno | Tricuspid regurgitation | 6.51e-04 | 77 | 27 | 4 | HP:0005180 | |
| HumanPheno | Abnormal magnesium concentration | 7.12e-04 | 34 | 27 | 3 | HP:0004921 | |
| HumanPheno | Abnormal circulating unsaturated fatty acid concentration | 7.43e-04 | 8 | 27 | 2 | HP:0011022 | |
| HumanPheno | Hyperactive renin-angiotensin system | 7.43e-04 | 8 | 27 | 2 | HP:0000841 | |
| HumanPheno | Late-onset proximal muscle weakness | 7.43e-04 | 8 | 27 | 2 | HP:0003694 | |
| HumanPheno | Abnormal circulating eicosanoid concentration | 7.43e-04 | 8 | 27 | 2 | HP:0030361 | |
| HumanPheno | Abnormal tricuspid valve physiology | 7.52e-04 | 80 | 27 | 4 | HP:0031651 | |
| HumanPheno | Abnormal adrenal morphology | 8.49e-04 | 145 | 27 | 5 | HP:0011732 | |
| HumanPheno | Abnormal endocrine morphology | 8.49e-04 | 145 | 27 | 5 | HP:0031071 | |
| HumanPheno | Abnormal T-wave | 9.15e-04 | 37 | 27 | 3 | HP:0005135 | |
| HumanPheno | Hypokalemic metabolic alkalosis | 9.52e-04 | 9 | 27 | 2 | HP:0001960 | |
| HumanPheno | Periodic hypokalemic paresis | 9.52e-04 | 9 | 27 | 2 | HP:0008153 | |
| HumanPheno | Increased urinary potassium | 9.52e-04 | 9 | 27 | 2 | HP:0003081 | |
| HumanPheno | Adrenocortical adenoma | 9.52e-04 | 9 | 27 | 2 | HP:0008256 | |
| HumanPheno | Impaired renal function | 9.52e-04 | 9 | 27 | 2 | HP:0000087 | |
| HumanPheno | Respiratory paralysis | 9.52e-04 | 9 | 27 | 2 | HP:0002203 | |
| HumanPheno | Postprandial hyperglycemia | 9.52e-04 | 9 | 27 | 2 | HP:0011998 | |
| HumanPheno | Abnormal ST segment | 1.07e-03 | 39 | 27 | 3 | HP:0012249 | |
| HumanPheno | EEG with abnormally slow frequencies | 1.08e-03 | 88 | 27 | 4 | HP:0011203 | |
| HumanPheno | Prolonged PR interval | 1.19e-03 | 10 | 27 | 2 | HP:0012248 | |
| HumanPheno | Hypernatriuria | 1.19e-03 | 10 | 27 | 2 | HP:0012605 | |
| HumanPheno | Apneic episodes in infancy | 1.19e-03 | 10 | 27 | 2 | HP:0005949 | |
| HumanPheno | Impaired myocardial contractility | 1.19e-03 | 10 | 27 | 2 | HP:0006670 | |
| HumanPheno | Abnormal retinal morphology | CACNA1B DPAGT1 FLVCR1 MCOLN1 TXNDC15 CLCNKB FZD5 PGAP1 SCN3A SCN8A SELENOI SLC24A1 USH2A | 1.42e-03 | 1065 | 27 | 13 | HP:0000479 |
| HumanPheno | Periodic paralysis | 1.44e-03 | 11 | 27 | 2 | HP:0003768 | |
| HumanPheno | Acute kidney injury | 1.52e-03 | 44 | 27 | 3 | HP:0001919 | |
| HumanPheno | Abnormality of aldosterone production | 1.52e-03 | 44 | 27 | 3 | HP:0002855 | |
| HumanPheno | Hypokalemic alkalosis | 1.73e-03 | 12 | 27 | 2 | HP:0001949 | |
| HumanPheno | Fetal polyuria | 1.73e-03 | 12 | 27 | 2 | HP:0001563 | |
| HumanPheno | Exercise-induced muscle fatigue | 1.73e-03 | 12 | 27 | 2 | HP:0009020 | |
| Domain | Olfact_rcpt | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR7C1 OR5AU1 OR6K2 OR9I1 OR6Q1 OR9Q2 OR9Q1 OR6C74 OR1F2P OR13G1 OR5T2 OR6C65 OR2T11 OR1J4 OR6K6 OR1J2 OR1F1 OR2T3 OR51B5 OR2A12 OR6C2 OR6C4 OR2A4 OR7D2 OR51I2 OR1E1 OR7A17 OR7A10 OR9A2 OR4F6 | 5.94e-36 | 393 | 111 | 38 | IPR000725 |
| Domain | 7tm_1 | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR7C1 GPR33 OR5AU1 OR6K2 OR9I1 OR6Q1 OR9Q2 OR9Q1 OR6C74 OR1F2P OR13G1 OR5T2 GPR63 OR6C65 OR2T11 OR1J4 OR6K6 OR1J2 OR1F1 OR2T3 OR51B5 OR2A12 OR6C2 ACKR3 OR6C4 OR2A4 OR7D2 OR51I2 OR1E1 OR7A17 OR7A10 OR9A2 OR4F6 | 1.06e-30 | 677 | 111 | 41 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR7C1 GPR33 OR5AU1 OR6K2 OR9I1 OR6Q1 OR9Q2 OR9Q1 OR6C74 OR1F2P OR13G1 OR5T2 GPR63 OR6C65 OR2T11 OR1J4 OR6K6 OR1J2 OR1F1 OR2T3 OR51B5 OR2A12 OR6C2 ACKR3 OR6C4 OR2A4 OR7D2 OR51I2 OR1E1 OR7A17 OR7A10 OR9A2 OR4F6 | 1.69e-30 | 685 | 111 | 41 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR7C1 GPR33 OR5AU1 OR6K2 OR9I1 OR6Q1 OR9Q2 OR9Q1 OR6C74 OR1F2P OR13G1 OR5T2 GPR63 OR6C65 OR2T11 OR1J4 OR6K6 OR1J2 OR1F1 OR2T3 OR51B5 OR2A12 OR6C2 ACKR3 OR6C4 OR2A4 OR7D2 OR51I2 OR1E1 OR7A17 OR7A10 OR9A2 OR4F6 | 2.38e-30 | 691 | 111 | 41 | PS50262 |
| Domain | GPCR_Rhodpsn | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR7C1 GPR33 OR5AU1 OR6K2 OR9I1 OR6Q1 OR9Q2 OR9Q1 OR6C74 OR1F2P OR13G1 OR5T2 GPR63 OR6C65 OR2T11 OR1J4 OR6K6 OR1J2 OR1F1 OR2T3 OR51B5 OR2A12 OR6C2 ACKR3 OR6C4 OR2A4 OR7D2 OR51I2 OR1E1 OR7A17 OR7A10 OR9A2 OR4F6 | 2.53e-30 | 692 | 111 | 41 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR7C1 GPR33 OR5AU1 OR6K2 OR9I1 OR6Q1 OR9Q2 OR9Q1 OR6C74 OR13G1 OR5T2 GPR63 OR6C65 OR2T11 OR1J4 OR6K6 OR1J2 OR1F1 OR2T3 OR51B5 OR2A12 OR6C2 ACKR3 OR6C4 OR2A4 OR7D2 OR51I2 OR1E1 OR7A17 OR7A10 OR9A2 OR4F6 | 1.16e-29 | 670 | 111 | 40 | IPR017452 |
| Domain | Channel_four-helix_dom | CACNA1B CACNA1S TPCN1 CATSPER2 SCN3A SCN4A SCN5A SCN7A SCN8A SCN10A CACNA1I CACNA1H | 5.97e-16 | 57 | 111 | 12 | IPR027359 |
| Domain | - | CACNA1B CACNA1S TPCN1 CATSPER2 SCN3A SCN4A SCN5A SCN7A SCN8A SCN10A CACNA1I CACNA1H | 5.97e-16 | 57 | 111 | 12 | 1.20.120.350 |
| Domain | Ion_trans_dom | CACNA1B CACNA1S MCOLN1 TPCN1 TRPM5 CATSPER2 SCN3A SCN4A SCN5A SCN7A SCN8A SCN10A CACNA1I CACNA1H | 5.63e-15 | 114 | 111 | 14 | IPR005821 |
| Domain | Ion_trans | CACNA1B CACNA1S MCOLN1 TPCN1 TRPM5 CATSPER2 SCN3A SCN4A SCN5A SCN7A SCN8A SCN10A CACNA1I CACNA1H | 5.63e-15 | 114 | 111 | 14 | PF00520 |
| Domain | Na_channel_asu | 7.92e-12 | 10 | 111 | 6 | IPR001696 | |
| Domain | Na_trans_assoc | 7.92e-12 | 10 | 111 | 6 | IPR010526 | |
| Domain | Na_trans_assoc | 7.92e-12 | 10 | 111 | 6 | PF06512 | |
| Domain | VDCCAlpha1 | 2.41e-07 | 10 | 111 | 4 | IPR002077 | |
| Domain | K/Na/Ca-exchanger | 2.03e-06 | 5 | 111 | 3 | IPR004481 | |
| Domain | Na_trans_cytopl | 4.03e-06 | 6 | 111 | 3 | PF11933 | |
| Domain | Na_trans_cytopl | 4.03e-06 | 6 | 111 | 3 | IPR024583 | |
| Domain | IQ_motif_EF-hand-BS | 1.60e-05 | 90 | 111 | 6 | IPR000048 | |
| Domain | TAS2R | 1.60e-05 | 26 | 111 | 4 | PF05296 | |
| Domain | T2R | 1.60e-05 | 26 | 111 | 4 | IPR007960 | |
| Domain | NaCa_Exmemb | 1.67e-05 | 9 | 111 | 3 | IPR004837 | |
| Domain | Na_Ca_ex | 1.67e-05 | 9 | 111 | 3 | PF01699 | |
| Domain | Cl_channel-K | 3.50e-05 | 2 | 111 | 2 | IPR002250 | |
| Domain | ABC_A | 4.32e-05 | 12 | 111 | 3 | IPR026082 | |
| Domain | VDCC_T_a1 | 1.05e-04 | 3 | 111 | 2 | IPR005445 | |
| Domain | IQ | 1.21e-04 | 81 | 111 | 5 | SM00015 | |
| Domain | ABC_TRANSPORTER_2 | 1.88e-04 | 48 | 111 | 4 | PS50893 | |
| Domain | ABC_tran | 1.88e-04 | 48 | 111 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 2.04e-04 | 49 | 111 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 2.20e-04 | 50 | 111 | 4 | IPR003439 | |
| Domain | IQ | 2.32e-04 | 93 | 111 | 5 | PS50096 | |
| Domain | GPHH_dom | 7.21e-04 | 7 | 111 | 2 | IPR031649 | |
| Domain | VDCC_a1su_IQ | 7.21e-04 | 7 | 111 | 2 | IPR014873 | |
| Domain | Ca_chan_IQ | 7.21e-04 | 7 | 111 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 7.21e-04 | 7 | 111 | 2 | PF08763 | |
| Domain | GPHH | 7.21e-04 | 7 | 111 | 2 | PF16905 | |
| Domain | IQ | 8.45e-04 | 71 | 111 | 4 | PF00612 | |
| Domain | Cl-channel_core | 1.23e-03 | 9 | 111 | 2 | IPR014743 | |
| Domain | - | 1.23e-03 | 9 | 111 | 2 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 1.23e-03 | 9 | 111 | 2 | PF00654 | |
| Domain | Cl-channel_volt-gated | 1.23e-03 | 9 | 111 | 2 | IPR001807 | |
| Domain | Frizzled | 1.86e-03 | 11 | 111 | 2 | IPR000539 | |
| Domain | Frizzled | 1.86e-03 | 11 | 111 | 2 | PF01534 | |
| Domain | Frizzled | 1.86e-03 | 11 | 111 | 2 | SM01330 | |
| Domain | 2pore_dom_K_chnl | 3.49e-03 | 15 | 111 | 2 | IPR003280 | |
| Domain | CBS | 3.98e-03 | 16 | 111 | 2 | SM00116 | |
| Domain | Frizzled/SFRP | 3.98e-03 | 16 | 111 | 2 | IPR015526 | |
| Domain | FRI | 6.20e-03 | 20 | 111 | 2 | SM00063 | |
| Domain | CBS_dom | 6.20e-03 | 20 | 111 | 2 | IPR000644 | |
| Domain | CBS | 6.20e-03 | 20 | 111 | 2 | PF00571 | |
| Domain | CBS | 6.20e-03 | 20 | 111 | 2 | PS51371 | |
| Domain | K_chnl_dom | 6.83e-03 | 21 | 111 | 2 | IPR013099 | |
| Domain | Ion_trans_2 | 6.83e-03 | 21 | 111 | 2 | PF07885 | |
| Domain | - | 6.83e-03 | 21 | 111 | 2 | 1.10.2000.10 | |
| Domain | EF-hand-dom_pair | 7.37e-03 | 287 | 111 | 6 | IPR011992 | |
| Domain | MFS_dom | 8.40e-03 | 134 | 111 | 4 | IPR020846 | |
| Domain | Frizzled_dom | 8.87e-03 | 24 | 111 | 2 | IPR020067 | |
| Domain | FZ | 8.87e-03 | 24 | 111 | 2 | PS50038 | |
| Domain | Fz | 8.87e-03 | 24 | 111 | 2 | PF01392 | |
| Domain | TM4_1 | 1.04e-02 | 26 | 111 | 2 | PS00421 | |
| Domain | AAA+_ATPase | 1.07e-02 | 144 | 111 | 4 | IPR003593 | |
| Domain | AAA | 1.07e-02 | 144 | 111 | 4 | SM00382 | |
| Domain | MARVEL | 1.12e-02 | 27 | 111 | 2 | PF01284 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR5G3 OR7C1 OR5AU1 OR6K2 OR11H7 OR9I1 OR6Q1 OR9Q2 OR9Q1 OR6C74 OR13G1 OR5T2 OR6C65 OR2T11 OR1J4 OR6K6 OR1J2 OR1F1 OR2T3 OR51B5 TAS2R4 TAS2R10 OR2A12 TRPM5 OR6C2 OR6C4 OR2A4 OR7D2 OR51I2 SCN3A OR1E1 OR7A17 SLC24A1 TAS2R50 OR7A10 OR9A2 OR4F6 | 1.20e-34 | 636 | 98 | 45 | M41834 |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR5G3 OR7C1 OR5AU1 OR6K2 OR11H7 OR9I1 OR6Q1 OR9Q2 OR9Q1 OR6C74 OR13G1 OR5T2 OR6C65 OR2T11 OR1J4 OR6K6 OR1J2 OR1F1 OR2T3 OR51B5 OR2A12 OR6C2 OR6C4 OR2A4 OR7D2 OR51I2 OR1E1 OR7A17 OR7A10 OR9A2 OR4F6 | 2.73e-34 | 417 | 98 | 39 | M4072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR7C1 OR5AU1 OR6K2 OR9I1 OR6Q1 OR9Q2 OR9Q1 OR6C74 OR13G1 OR5T2 OR6C65 OR2T11 OR1J4 OR6K6 OR1J2 OR1F1 OR2T3 OR51B5 OR2A12 OR6C2 OR6C4 OR2A4 OR7D2 OR51I2 OR1E1 OR7A17 OR7A10 OR9A2 OR4F6 | 1.09e-32 | 389 | 98 | 37 | M14091 |
| Pathway | WP_GPCRS_ODORANT | OR2A7 OR7A5 OR1J1 GPR33 OR5T2 GPR63 TAS2R10 OR2A4 OR1E1 TAS2R60 OR7A17 TAS2R50 OR7A10 | 5.84e-11 | 157 | 98 | 13 | MM15872 |
| Pathway | WP_GPCRS_OTHER | OR2A7 OR7A5 OR1J1 OR1F2P OR1F1 FZD5 OR2A4 OR1E1 OR7A17 OR7A10 | 1.14e-09 | 96 | 98 | 10 | MM15939 |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 6.19e-08 | 31 | 98 | 6 | M877 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 6.54e-08 | 52 | 98 | 7 | M5785 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 7.57e-08 | 32 | 98 | 6 | M27455 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCC1 ADCY4 ATP6AP1 FLVCR1 SLC24A3 MFSD4B MCOLN1 SLC29A2 ABCA9 ABCA8 TPCN1 SLC5A4 TRPM5 SLCO4C1 CLCNKA CLCNKB ABCA6 SLC24A2 ATP1B2 SLC24A1 | 1.27e-07 | 736 | 98 | 20 | M27287 |
| Pathway | REACTOME_MUSCLE_CONTRACTION | KCNK18 SCN3A SCN4A SCN5A SCN7A SCN8A KCNK10 SCN10A CACNA1I CACNA1H ATP1B2 | 1.58e-07 | 203 | 98 | 11 | M5485 |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.88e-07 | 130 | 98 | 9 | M27454 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCC1 ATP6AP1 FLVCR1 SLC24A3 MCOLN1 SLC29A2 ABCA9 ABCA8 TPCN1 SLC5A4 TRPM5 SLCO4C1 CLCNKA CLCNKB ABCA6 SLC24A2 ATP1B2 SLC24A1 | 8.94e-07 | 681 | 98 | 18 | MM14985 |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 1.76e-05 | 23 | 98 | 4 | M47666 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 1.78e-05 | 47 | 98 | 5 | M42524 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 2.48e-05 | 25 | 98 | 4 | M47948 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 5.16e-05 | 11 | 98 | 3 | M27336 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 8.09e-05 | 260 | 98 | 9 | M39397 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 8.86e-05 | 13 | 98 | 3 | MM15078 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 1.22e-04 | 37 | 98 | 4 | MM15067 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 1.50e-04 | 39 | 98 | 4 | M793 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.95e-04 | 121 | 98 | 6 | M872 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 2.23e-04 | 176 | 98 | 7 | MM15718 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 2.41e-04 | 44 | 98 | 4 | M11911 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 2.84e-04 | 183 | 98 | 7 | M997 | |
| Pathway | WP_GPCRS_OTHER | 4.70e-04 | 93 | 98 | 5 | M39629 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 6.25e-04 | 99 | 98 | 5 | MM14910 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 7.05e-04 | 6 | 98 | 2 | M47762 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 8.53e-04 | 106 | 98 | 5 | M27200 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 1.27e-03 | 31 | 98 | 3 | MM15691 | |
| Pathway | REACTOME_SIGNALING_BY_RNF43_MUTANTS | 1.30e-03 | 8 | 98 | 2 | M27433 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.74e-03 | 249 | 98 | 7 | M5988 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.88e-03 | 186 | 98 | 6 | MM15994 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 2.53e-03 | 11 | 98 | 2 | M47958 | |
| Pathway | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | 2.53e-03 | 11 | 98 | 2 | MM14547 | |
| Pathway | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | 3.02e-03 | 12 | 98 | 2 | M1071 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 3.07e-03 | 42 | 98 | 3 | M7169 | |
| Pubmed | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR5G3 OR7C1 OR5AU1 OR6K2 OR11H7 OR9I1 OR9Q2 OR9Q1 OR6C74 OR1F2P OR13G1 OR5T2 OR6C65 OR1J4 OR6K6 OR9A1P OR1F1 OR2A12 OR6C2 OR2A4 OR51I2 OR1E1 OR7A17 OR7A10 OR9A2 OR4F6 | 7.02e-41 | 343 | 114 | 34 | 32295537 | |
| Pubmed | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR5G3 OR7C1 OR5AU1 OR6K2 OR11H7 OR9I1 OR9Q2 OR9Q1 OR6C74 OR1F2P OR13G1 OR5T2 OR6C65 OR1J4 OR6K6 OR9A1P OR1F1 OR2A12 OR6C2 OR2A4 OR51I2 OR1E1 OR7A17 OR7A10 OR9A2 OR4F6 | 9.52e-41 | 346 | 114 | 34 | 14611657 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR5G3 OR7C1 OR5AU1 OR6K2 OR11H7 OR9I1 OR9Q2 OR9Q1 OR6C74 OR1F2P OR13G1 OR5T2 OR6C65 OR1J4 OR9A1P OR1F1 OR2A12 OR6C2 OR2A4 OR51I2 OR1E1 OR7A17 OR7A10 OR9A2 OR4F6 | 2.43e-39 | 340 | 114 | 33 | 11875048 |
| Pubmed | OR8I2 OR2A7 OR9A4 OR11G2 OR6N2 OR7A5 OR1J1 OR5G3 OR7C1 OR5AU1 OR6K2 OR11H7 OR9I1 OR9Q2 OR9Q1 OR6C74 OR1F2P OR13G1 OR5T2 OR6C65 OR1J4 OR9A1P OR1F1 OR2A12 OR6C2 OR2A4 OR51I2 OR1E1 OR7A17 OR7A10 OR9A2 OR4F6 | 1.09e-37 | 340 | 114 | 32 | 11802173 | |
| Pubmed | OR8I2 OR2A7 OR9A4 OR6S1 OR11G2 OR6N2 OR7A5 OR1J1 OR5G3 OR7C1 OR5AU1 OR6K2 OR11H7 OR9I1 OR6Q1 OR6C74 OR1F2P OR13G1 OR5T2 OR2T11 OR1J4 OR6K6 OR1J2 OR1F1 OR51B5 OR2A12 OR6C4 OR2A4 OR7D2 OR51I2 OR1E1 OR7A17 OR7A10 OR9A2 OR4F6 | 1.53e-35 | 541 | 114 | 35 | 14983052 | |
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | OR8I2 OR2A7 OR11G2 OR7A5 OR1J1 OR7C1 OR5AU1 OR11H7 OR9I1 OR6Q1 OR9Q1 OR1F2P OR1J4 OR1J2 OR1F1 OR2A12 OR7D2 OR1E1 OR7A17 OR7A10 | 2.27e-23 | 219 | 114 | 20 | 12213199 |
| Pubmed | 2.49e-17 | 23 | 114 | 9 | 10706615 | ||
| Pubmed | Expression of members of the putative olfactory receptor gene family in mammalian germ cells. | 1.07e-14 | 25 | 114 | 8 | 1370859 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | CACNA1B CACNA1S KCNK18 CLCNKA CLCNKB SCN3A SCN4A SCN5A SCN7A SCN8A SCN10A CACNA1H | 4.00e-14 | 139 | 114 | 12 | 16985003 |
| Pubmed | Evolution of odorant receptors expressed in mammalian testes. | 1.83e-12 | 13 | 114 | 6 | 11014824 | |
| Pubmed | Odorant and vomeronasal receptor genes in two mouse genome assemblies. | 2.93e-12 | 74 | 114 | 9 | 15081110 | |
| Pubmed | 3.19e-12 | 14 | 114 | 6 | 7528109 | ||
| Pubmed | 4.32e-11 | 9 | 114 | 5 | 16382098 | ||
| Pubmed | 5.46e-10 | 5 | 114 | 4 | 17724025 | ||
| Pubmed | 7.59e-09 | 8 | 114 | 4 | 28330839 | ||
| Pubmed | 1.36e-08 | 9 | 114 | 4 | 16382099 | ||
| Pubmed | 1.36e-08 | 9 | 114 | 4 | 15746173 | ||
| Pubmed | Specific repertoire of olfactory receptor genes in the male germ cells of several mammalian species. | 1.40e-08 | 24 | 114 | 5 | 9119360 | |
| Pubmed | 2.64e-08 | 27 | 114 | 5 | 12581520 | ||
| Pubmed | Modulation of the combinatorial code of odorant receptor response patterns in odorant mixtures. | 2.64e-08 | 27 | 114 | 5 | 32061665 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 27315375 | ||
| Pubmed | 7.65e-08 | 13 | 114 | 4 | 15123669 | ||
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 26631410 | ||
| Pubmed | Chromosomal location-dependent nonstochastic onset of odor receptor expression. | 2.52e-07 | 17 | 114 | 4 | 20668191 | |
| Pubmed | Olfactory receptors and signalling elements in the Grueneberg ganglion. | 2.52e-07 | 17 | 114 | 4 | 16805845 | |
| Pubmed | Expression of potassium-dependent sodium-calcium exchanger in the murine lens. | 3.41e-07 | 5 | 114 | 3 | 29128492 | |
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 3.41e-07 | 5 | 114 | 3 | 22875929 | |
| Pubmed | Evolutionary analysis of a cluster of ATP-binding cassette (ABC) genes. | 3.41e-07 | 5 | 114 | 3 | 12532264 | |
| Pubmed | 6.81e-07 | 6 | 114 | 3 | 8929536 | ||
| Pubmed | 6.81e-07 | 6 | 114 | 3 | 23711479 | ||
| Pubmed | Sodium/calcium exchanger expression in the mouse and rat olfactory systems. | 6.81e-07 | 6 | 114 | 3 | 17311327 | |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 6.81e-07 | 6 | 114 | 3 | 23652591 | |
| Pubmed | Evolutionary relationships of the Tas2r receptor gene families in mouse and human. | 7.65e-07 | 22 | 114 | 4 | 12734386 | |
| Pubmed | The molecular receptive ranges of human TAS2R bitter taste receptors. | 9.24e-07 | 23 | 114 | 4 | 20022913 | |
| Pubmed | The chromosomal distribution of mouse odorant receptor genes. | 9.64e-07 | 54 | 114 | 5 | 8570653 | |
| Pubmed | 1.11e-06 | 24 | 114 | 4 | 24152035 | ||
| Pubmed | 1.31e-06 | 25 | 114 | 4 | 12139982 | ||
| Pubmed | Molecular mechanisms of bitter and sweet taste transduction. | 1.55e-06 | 26 | 114 | 4 | 11696554 | |
| Pubmed | Lineage-specific loss of function of bitter taste receptor genes in humans and nonhuman primates. | 2.11e-06 | 28 | 114 | 4 | 15744053 | |
| Pubmed | Adaptive diversification of bitter taste receptor genes in Mammalian evolution. | 2.81e-06 | 30 | 114 | 4 | 12679530 | |
| Pubmed | 4.71e-06 | 34 | 114 | 4 | 15496549 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 7.38e-06 | 12 | 114 | 3 | 30175250 | |
| Pubmed | A common genetic variant within SCN10A modulates cardiac SCN5A expression. | 1.07e-05 | 2 | 114 | 2 | 24642470 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 32641496 | ||
| Pubmed | Cloning, tissue distribution, and intrarenal localization of ClC chloride channels in human kidney. | 1.07e-05 | 2 | 114 | 2 | 8544406 | |
| Pubmed | A T-type calcium channel required for normal function of a mammalian mechanoreceptor. | 1.07e-05 | 2 | 114 | 2 | 12808460 | |
| Pubmed | The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron. | 1.07e-05 | 2 | 114 | 2 | 27335120 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 8812470 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 25919862 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 24863058 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 25071191 | ||
| Pubmed | Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. | 1.07e-05 | 2 | 114 | 2 | 9916798 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 9916791 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 15047701 | ||
| Pubmed | Absence of ion channels CACN1AS and SCN4A mutations in thyrotoxic hypokalemic periodic paralysis. | 1.07e-05 | 2 | 114 | 2 | 15072700 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 36786913 | ||
| Pubmed | Tetraspanin-13 modulates voltage-gated CaV2.2 Ca2+ channels. | 1.07e-05 | 2 | 114 | 2 | 23648579 | |
| Pubmed | Ca2+-dependent regulation of sodium channels NaV1.4 and NaV1.5 is controlled by the post-IQ motif. | 1.07e-05 | 2 | 114 | 2 | 30944319 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 31292628 | ||
| Pubmed | Expanding Genotype-Phenotype Correlation of CLCNKA and CLCNKB Variants Linked to Hearing Loss. | 1.07e-05 | 2 | 114 | 2 | 38069401 | |
| Pubmed | Mutation analysis of CACNA1S and SCN4A in patients with hypokalemic periodic paralysis. | 1.07e-05 | 2 | 114 | 2 | 26252573 | |
| Pubmed | Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. | 1.07e-05 | 2 | 114 | 2 | 19118277 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 11834499 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 35759432 | ||
| Pubmed | A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels. | 1.07e-05 | 2 | 114 | 2 | 20805576 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 30714145 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 10662833 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 34608571 | ||
| Pubmed | Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. | 1.07e-05 | 2 | 114 | 2 | 24998131 | |
| Pubmed | Genotype and phenotype analysis of patients with sporadic periodic paralysis. | 1.07e-05 | 2 | 114 | 2 | 21841462 | |
| Pubmed | Salt wasting and deafness resulting from mutations in two chloride channels. | 1.07e-05 | 2 | 114 | 2 | 15044642 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 24360055 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 34399820 | ||
| Pubmed | Two highly homologous members of the ClC chloride channel family in both rat and human kidney. | 1.07e-05 | 2 | 114 | 2 | 8041726 | |
| Pubmed | A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane. | 1.07e-05 | 2 | 114 | 2 | 18648499 | |
| Pubmed | The Low-Threshold Calcium Channel Cav3.2 Determines Low-Threshold Mechanoreceptor Function. | 1.07e-05 | 2 | 114 | 2 | 25600872 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 11014860 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 32330377 | ||
| Pubmed | 1.52e-05 | 15 | 114 | 3 | 24428937 | ||
| Pubmed | 1.61e-05 | 46 | 114 | 4 | 32126975 | ||
| Pubmed | Natural selection on the olfactory receptor gene family in humans and chimpanzees. | 2.26e-05 | 17 | 114 | 3 | 12908129 | |
| Pubmed | Human CLC-K Channels Require Palmitoylation of Their Accessory Subunit Barttin to Be Functional. | 3.19e-05 | 3 | 114 | 2 | 26013830 | |
| Pubmed | Barttin increases surface expression and changes current properties of ClC-K channels. | 3.19e-05 | 3 | 114 | 2 | 12111250 | |
| Pubmed | Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C. | 3.19e-05 | 3 | 114 | 2 | 23488970 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 26488564 | ||
| Pubmed | Association of Catsper1 or -2 with Ca(v)3.3 leads to suppression of T-type calcium channel activity. | 3.19e-05 | 3 | 114 | 2 | 16740636 | |
| Pubmed | Differential interactions of Na+ channel toxins with T-type Ca2+ channels. | 3.19e-05 | 3 | 114 | 2 | 18591418 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 26692363 | ||
| Pubmed | Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart. | 3.19e-05 | 3 | 114 | 2 | 11230107 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 17510212 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 28846697 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 19699781 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 33547341 | ||
| Pubmed | Calmodulin regulates Cav3 T-type channels at their gating brake. | 3.19e-05 | 3 | 114 | 2 | 28972185 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 23063126 | ||
| Pubmed | Mutation spectrum and health status in skeletal muscle channelopathies in Japan. | 3.19e-05 | 3 | 114 | 2 | 32660787 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 11927664 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 11520064 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 20038812 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 28366770 | ||
| Interaction | SCN11A interactions | 3.53e-07 | 15 | 83 | 4 | int:SCN11A | |
| Interaction | YIPF3 interactions | 9.89e-07 | 186 | 83 | 8 | int:YIPF3 | |
| Interaction | MFSD12 interactions | 1.13e-05 | 34 | 83 | 4 | int:MFSD12 | |
| Interaction | SCN5A interactions | 4.17e-05 | 47 | 83 | 4 | int:SCN5A | |
| Interaction | SCN8A interactions | 7.30e-05 | 20 | 83 | 3 | int:SCN8A | |
| Interaction | FZD8 interactions | 1.12e-04 | 23 | 83 | 3 | int:FZD8 | |
| Interaction | CACNA1D interactions | 1.28e-04 | 24 | 83 | 3 | int:CACNA1D | |
| Interaction | GPR89A interactions | 1.38e-04 | 120 | 83 | 5 | int:GPR89A | |
| Interaction | TSPAN15 interactions | 1.43e-04 | 276 | 83 | 7 | int:TSPAN15 | |
| Interaction | SCN1A interactions | 2.28e-04 | 29 | 83 | 3 | int:SCN1A | |
| Cytoband | 11q12.1 | 1.72e-07 | 161 | 114 | 7 | 11q12.1 | |
| Cytoband | 12q13.2 | 1.12e-05 | 55 | 114 | 4 | 12q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 2.63e-05 | 345 | 114 | 7 | chr11q12 | |
| Cytoband | 1q23.1 | 2.09e-04 | 46 | 114 | 3 | 1q23.1 | |
| Cytoband | 7q35 | 3.56e-04 | 55 | 114 | 3 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 6.09e-04 | 66 | 114 | 3 | chr7q35 | |
| Cytoband | 14q11.2 | 1.09e-03 | 180 | 114 | 4 | 14q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q34 | 1.21e-03 | 185 | 114 | 4 | chr7q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q24 | 1.91e-03 | 98 | 114 | 3 | chr17q24 | |
| Cytoband | 1q44 | 2.65e-03 | 110 | 114 | 3 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 4.06e-03 | 128 | 114 | 3 | chr1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 4.19e-03 | 423 | 114 | 5 | chr12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q33 | 5.01e-03 | 138 | 114 | 3 | chr9q33 | |
| GeneFamily | Olfactory receptors, family 6 | 7.00e-12 | 51 | 98 | 9 | 153 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 5.23e-10 | 9 | 98 | 5 | 1203 | |
| GeneFamily | Olfactory receptors, family 9 | 2.04e-09 | 23 | 98 | 6 | 156 | |
| GeneFamily | Olfactory receptors, family 1 | 7.18e-08 | 40 | 98 | 6 | 147 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.11e-05 | 26 | 98 | 4 | 253 | |
| GeneFamily | ATP binding cassette subfamily A | 5.38e-05 | 14 | 98 | 3 | 805 | |
| GeneFamily | Taste 2 receptors | 5.77e-05 | 39 | 98 | 4 | 1162 | |
| GeneFamily | Olfactory receptors, family 7 | 3.73e-04 | 113 | 98 | 5 | 154 | |
| GeneFamily | Olfactory receptors, family 2 | 3.73e-04 | 113 | 98 | 5 | 149 | |
| GeneFamily | Chloride voltage-gated channels | 1.27e-03 | 10 | 98 | 2 | 302 | |
| GeneFamily | Solute carriers | FLVCR1 SLC24A3 SLC29A2 SLC5A4 SLCO4C1 SLC24A2 SLC10A5 SLC24A1 | 1.37e-03 | 395 | 98 | 8 | 752 |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 1.55e-03 | 11 | 98 | 2 | 286 | |
| GeneFamily | Potassium two pore domain channel subfamily K | 2.92e-03 | 15 | 98 | 2 | 277 | |
| GeneFamily | Olfactory receptors, family 11 | 6.83e-03 | 23 | 98 | 2 | 159 | |
| GeneFamily | Transient receptor potential cation channels | 1.00e-02 | 28 | 98 | 2 | 249 | |
| GeneFamily | CD molecules|Tetraspanins | 1.38e-02 | 33 | 98 | 2 | 768 | |
| Coexpression | KONDO_PROSTATE_CANCER_WITH_H3K27ME3 | 1.27e-06 | 194 | 106 | 8 | M7281 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 4.03e-07 | 179 | 114 | 7 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.41e-07 | 187 | 114 | 7 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-06 | 171 | 114 | 6 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.42e-06 | 172 | 114 | 6 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.74e-06 | 187 | 114 | 6 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.05e-05 | 193 | 114 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.05e-05 | 193 | 114 | 6 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.08e-05 | 194 | 114 | 6 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.11e-05 | 195 | 114 | 6 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.11e-05 | 195 | 114 | 6 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-05 | 200 | 114 | 6 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | RV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 2.46e-05 | 134 | 114 | 5 | 8c4046ba1f85172915a112499e492c3efe8474c2 | |
| ToppCell | RV-14._Fibroblast_III|RV / Chamber and Cluster_Paper | 3.04e-05 | 140 | 114 | 5 | b4fee8eb6bf855b364b00bda3f78e49d851bbca0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.22e-05 | 150 | 114 | 5 | 1270f33f9d7e46e55adf1a96e8beee858b95589d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.22e-05 | 150 | 114 | 5 | 156118ce1d69522624196410cba18b8354cd0bb4 | |
| ToppCell | Control-Epithelial-Ionocyte|Epithelial / Disease state, Lineage and Cell class | 4.94e-05 | 155 | 114 | 5 | 4b9369b203a4d7071c56d3d8e6b450e9a0121c41 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.41e-05 | 158 | 114 | 5 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.57e-05 | 159 | 114 | 5 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.57e-05 | 159 | 114 | 5 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-05 | 165 | 114 | 5 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-05 | 165 | 114 | 5 | 21a82a975f550080b6674750b06212205cd16742 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-05 | 165 | 114 | 5 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-05 | 168 | 114 | 5 | ce9fae8b295c668b0959d5007a8bcd401d80e258 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.23e-05 | 168 | 114 | 5 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 7.43e-05 | 169 | 114 | 5 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 171 | 114 | 5 | 584a095ddcbf78aa29527f84b46b5ad3e2edbaa9 | |
| ToppCell | Endothelial-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 8.08e-05 | 172 | 114 | 5 | 8a527dff06d841a86c7eb04a1dd9630787294da4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-05 | 173 | 114 | 5 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Lymphatic_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 8.53e-05 | 174 | 114 | 5 | d551bc29afef071adf4c9bb80345352ec33441d8 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-plasma_cell-plasma_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.76e-05 | 175 | 114 | 5 | 28b29f844fa46fe579ddc19039fb2d9dc5f48f3b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.76e-05 | 175 | 114 | 5 | 787ac1a12cda10af5c8830471702a4cbaf43e79e | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-plasma_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.76e-05 | 175 | 114 | 5 | ac96ca9ca309b0d72a2f5af6a3b02c7f80755750 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.49e-05 | 178 | 114 | 5 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-04 | 182 | 114 | 5 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | 3'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-04 | 182 | 114 | 5 | 82d6f72649c7dd4d64a84a9795edebdef2f285d6 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-04 | 182 | 114 | 5 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.05e-04 | 182 | 114 | 5 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.11e-04 | 184 | 114 | 5 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 1.11e-04 | 184 | 114 | 5 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.14e-04 | 185 | 114 | 5 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | droplet-Thymus-nan-24m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 185 | 114 | 5 | e583f6601f9ed79b0b23d2f9426a4ba8b969230b | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-04 | 186 | 114 | 5 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 187 | 114 | 5 | 52ffd4be374e329ac8d321063f061b826d252956 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.20e-04 | 187 | 114 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.23e-04 | 188 | 114 | 5 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 1.23e-04 | 188 | 114 | 5 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-04 | 188 | 114 | 5 | e18065bbc26d6f3774fd1f478fb41d8fb555fa26 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-04 | 189 | 114 | 5 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 189 | 114 | 5 | 25db316f66cee53774bb2b286cc457b37353356c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-04 | 189 | 114 | 5 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Lymphatic|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.29e-04 | 190 | 114 | 5 | 8d6ec2fc0af19a5cb16fff34f8b131b71b33d45f | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.29e-04 | 190 | 114 | 5 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 190 | 114 | 5 | e64b191f928935484e2c993d7f8af0572a617a3a | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.32e-04 | 191 | 114 | 5 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.32e-04 | 191 | 114 | 5 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.32e-04 | 191 | 114 | 5 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.32e-04 | 191 | 114 | 5 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.32e-04 | 191 | 114 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 1.35e-04 | 192 | 114 | 5 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | droplet-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 192 | 114 | 5 | 42e4dafbe3e8b4a3c25d594f06b95430a1dd8b28 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.35e-04 | 192 | 114 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.35e-04 | 192 | 114 | 5 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | E15.5-Endothelial|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.35e-04 | 192 | 114 | 5 | 88cc7f14d031a0613d032eb01c93e88c72d3938f | |
| ToppCell | Neuroendocrine|World / Class top | 1.35e-04 | 192 | 114 | 5 | 0199da3ef9ddb6673e9aa41f346f374838aec182 | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 193 | 114 | 5 | 7cff1e859b296b1032eebcfc0f99a504f3bda2c9 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-04 | 193 | 114 | 5 | 040f6bb42aa41d0921371fdda1cc0912c4fe1930 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-04 | 193 | 114 | 5 | e468287c8b30c56d1de65e8347ade233ba6cf584 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.39e-04 | 193 | 114 | 5 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.39e-04 | 193 | 114 | 5 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 1.42e-04 | 194 | 114 | 5 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.42e-04 | 194 | 114 | 5 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | droplet-Lung-1m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-04 | 194 | 114 | 5 | 1ac52b00ea0b0ddbd04f5d85fa8c086980a78926 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.42e-04 | 194 | 114 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 194 | 114 | 5 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 194 | 114 | 5 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.42e-04 | 194 | 114 | 5 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 195 | 114 | 5 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.45e-04 | 195 | 114 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.45e-04 | 195 | 114 | 5 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 1.45e-04 | 195 | 114 | 5 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.45e-04 | 195 | 114 | 5 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | Skin-Tubules|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.49e-04 | 196 | 114 | 5 | 12e21cc310a261407b46e034108e8c93ea16e045 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.49e-04 | 196 | 114 | 5 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-04 | 197 | 114 | 5 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.53e-04 | 197 | 114 | 5 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-04 | 197 | 114 | 5 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.53e-04 | 197 | 114 | 5 | 31c8d6e565bbdc37843ce871fe91845b0cc18a9f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-04 | 197 | 114 | 5 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| ToppCell | COPD-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 1.56e-04 | 198 | 114 | 5 | 2f13c0b3372af53d1bd85f9546f315c878580a71 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-04 | 198 | 114 | 5 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 1.56e-04 | 198 | 114 | 5 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Control-Stromal|Control / Disease state, Lineage and Cell class | 1.56e-04 | 198 | 114 | 5 | ae726b6b7f0a4107899be4d32ac256ffa0bd8d59 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-04 | 198 | 114 | 5 | b3a020522e064bb61949d38e442f24026e339364 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-04 | 198 | 114 | 5 | fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-04 | 198 | 114 | 5 | 7a0c4dbc8c99968d42af00a718f4fedc544599ec | |
| ToppCell | COPD-Stromal-Fibroblast|COPD / Disease state, Lineage and Cell class | 1.56e-04 | 198 | 114 | 5 | 7904af61473cb20064f7a3a1e1bfe8d5913cf317 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-04 | 199 | 114 | 5 | 9672230aa0bc6a7289050c955f5154ca183a5159 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-04 | 199 | 114 | 5 | e18abe678da293bd01fae55e2f9ab6fdd643d02d | |
| ToppCell | Biopsy_IPF-Endothelial-Lymphatic_Endothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 1.60e-04 | 199 | 114 | 5 | 483b01f1308eb201a1ff3788fe656c486b6b9e66 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-04 | 199 | 114 | 5 | 4e128c705ad36fd840582848f278770f356fcc8b | |
| Drug | lamotrigine | CACNA1B CACNA1S TPCN1 KCNK18 SCN3A SCN4A SCN5A SCN7A SCN10A CACNA1I CACNA1H | 1.14e-11 | 116 | 111 | 11 | CID000003878 |
| Drug | bepridil | CACNA1B CACNA1S TPCN1 SCN3A SCN4A SCN5A SCN7A SCN10A CACNA1I CACNA1H SLC24A1 | 2.84e-11 | 126 | 111 | 11 | CID000002351 |
| Drug | verapamil | CACNA1B CACNA1S ABCC1 ADCY4 ABCA9 ABCA8 TPCN1 KCNK18 ABCA6 SCN3A SCN4A SCN5A SCN7A KCNK10 SCN10A CACNA1I CACNA1H | 2.45e-10 | 490 | 111 | 17 | CID000002520 |
| Drug | mibefradil | 8.72e-10 | 64 | 111 | 8 | CID000060662 | |
| Drug | riluzole | CACNA1B CACNA1S KCNK18 SCN3A SCN4A SCN5A SCN7A KCNK10 SCN10A CACNA1I CACNA1H | 9.24e-10 | 174 | 111 | 11 | CID000005070 |
| Drug | isradipine | CACNA1B CACNA1S TPCN1 SCN3A SCN4A SCN7A SCN10A CACNA1I CACNA1H | 1.47e-09 | 100 | 111 | 9 | CID000003784 |
| Drug | APETx1, Anthopleura elegantissima | 7.97e-09 | 6 | 111 | 4 | ctd:C475726 | |
| Drug | phenytoin | CACNA1B CACNA1S TPCN1 SC5D SCN3A SCN4A SCN5A SCN7A SCN10A CACNA1I CACNA1H | 1.03e-08 | 219 | 111 | 11 | CID000001775 |
| Drug | gabapentin | CACNA1B CACNA1S TPCN1 SCN3A SCN4A SCN5A SCN7A SCN10A CACNA1I CACNA1H | 1.05e-08 | 169 | 111 | 10 | CID000003446 |
| Drug | Zonisamide | 1.49e-08 | 17 | 111 | 5 | DB00909 | |
| Drug | NSC7524 | CACNA1B CACNA1S ADCY4 SCN3A SCN4A SCN5A SCN7A SCN10A CACNA1I CACNA1H | 2.13e-08 | 182 | 111 | 10 | CID000005657 |
| Drug | lanthanum | CACNA1B CACNA1S ADCY4 TPCN1 TRPM5 SLC24A2 ENTPD1 CACNA1I CACNA1H | 2.24e-08 | 136 | 111 | 9 | CID000023926 |
| Drug | sodium | CACNA1S ADCY4 ATP6AP1 SLC24A3 SLC29A2 TPCN1 SLC5A4 TRPM5 CLCNKA CLCNKB SLC24A2 MALL SCN3A SCN4A SCN5A SCN7A SCN10A CACNA1H ATP1B2 SLC24A1 | 2.77e-08 | 944 | 111 | 20 | CID000000923 |
| Drug | procaine | CACNA1B CACNA1S TPCN1 SCN3A SCN4A SCN7A SCN10A CACNA1I CACNA1H | 6.22e-08 | 153 | 111 | 9 | CID000004914 |
| Drug | potassium | CACNA1B CACNA1S ADCY4 SLC24A3 TPCN1 KCNK18 TRPM5 CLCNKA CLCNKB SLC24A2 SCN3A SCN4A SCN5A SCN7A KCNK10 SCN10A CACNA1I CACNA1H ATP1B2 SLC24A1 | 8.11e-08 | 1008 | 111 | 20 | CID000000813 |
| Drug | lidocaine | 9.14e-08 | 160 | 111 | 9 | CID000003676 | |
| Drug | AC1L1MOZ | 1.86e-07 | 27 | 111 | 5 | CID000031958 | |
| Drug | tocainide | 3.25e-07 | 30 | 111 | 5 | CID000038945 | |
| Drug | amiloride | CACNA1B CACNA1S SLC24A3 TPCN1 CLCNKA SLC24A2 MALL SCN4A CACNA1I CACNA1H SLC24A1 | 4.14e-07 | 315 | 111 | 11 | CID000016230 |
| Drug | propafenone | 5.19e-07 | 98 | 111 | 7 | CID000004932 | |
| Drug | methylglucamine | 5.77e-07 | 62 | 111 | 6 | CID000004049 | |
| Drug | zonisamide | 5.77e-07 | 62 | 111 | 6 | CID000005734 | |
| Drug | mexiletine | 8.39e-07 | 66 | 111 | 6 | CID000004178 | |
| Drug | pyraclofos | 8.86e-07 | 106 | 111 | 7 | CID000093460 | |
| Drug | Verapamil | 9.31e-07 | 16 | 111 | 4 | DB00661 | |
| Drug | benzocaine | 9.68e-07 | 37 | 111 | 5 | CID000002337 | |
| Drug | dibucaine | 1.00e-06 | 68 | 111 | 6 | CID000003025 | |
| Drug | diprafenone | 1.96e-06 | 19 | 111 | 4 | CID000071249 | |
| Drug | 3,4-dihydroquinazoline | 2.23e-06 | 6 | 111 | 3 | CID000583065 | |
| Drug | pilsicainide | 2.94e-06 | 46 | 111 | 5 | CID000004820 | |
| Drug | Barium permanganate | 4.06e-06 | 133 | 111 | 7 | CID000024587 | |
| Drug | Flumequine [42835-25-6]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 5.62e-06 | 197 | 111 | 8 | 5529_UP | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 6.20e-06 | 8 | 111 | 3 | ctd:C489827 | |
| Drug | AC1NT1AF | 6.25e-06 | 25 | 111 | 4 | CID005322157 | |
| Drug | Pirmenolum | 7.36e-06 | 26 | 111 | 4 | CID000004853 | |
| Drug | Cinildipine | 7.88e-06 | 56 | 111 | 5 | CID000002752 | |
| Drug | PbTx-1 | 8.61e-06 | 27 | 111 | 4 | CID006437089 | |
| Drug | nefopam | 8.61e-06 | 27 | 111 | 4 | CID000004450 | |
| Drug | Cinnarizine | 9.27e-06 | 9 | 111 | 3 | DB00568 | |
| Drug | Landel | 9.27e-06 | 9 | 111 | 3 | CID000163838 | |
| Drug | paraben | 1.00e-05 | 28 | 111 | 4 | CID000007175 | |
| Drug | nilvadipine | 1.11e-05 | 60 | 111 | 5 | CID000004494 | |
| Drug | quindine | 1.22e-05 | 219 | 111 | 8 | CID000001065 | |
| Drug | oxcarbazepine | 1.33e-05 | 30 | 111 | 4 | CID000034312 | |
| Drug | lercanidipine | 1.41e-05 | 63 | 111 | 5 | CID000065866 | |
| Drug | AC1L1CQC | 1.65e-05 | 65 | 111 | 5 | CID000002012 | |
| Drug | NSC93767 | 1.73e-05 | 32 | 111 | 4 | CID000005658 | |
| Drug | disopyramide | 1.77e-05 | 66 | 111 | 5 | CID000003114 | |
| Drug | Mibefradil | 1.81e-05 | 11 | 111 | 3 | DB01388 | |
| Drug | gallopamil | 1.91e-05 | 67 | 111 | 5 | CID000001234 | |
| Drug | CNS 1145 | 1.96e-05 | 33 | 111 | 4 | CID000190902 | |
| Drug | IHC-64 | 1.96e-05 | 33 | 111 | 4 | CID000162753 | |
| Drug | AC1L2AC7 | 2.21e-05 | 69 | 111 | 5 | CID000068733 | |
| Drug | 5-hydroxypropafenone | 2.22e-05 | 34 | 111 | 4 | CID000107927 | |
| Drug | nsc25485 | ABCC1 ADCY4 SLC24A3 SLCO4C1 SLC24A2 ENTPD1 SCN4A ATP1B2 SLC24A1 | 2.26e-05 | 312 | 111 | 9 | CID000004605 |
| Drug | Hexylcaine | 2.36e-05 | 2 | 111 | 2 | DB00473 | |
| Drug | Flecainide | 2.36e-05 | 2 | 111 | 2 | DB01195 | |
| Drug | AC1L2VU3 | 2.40e-05 | 12 | 111 | 3 | CID000129572 | |
| Drug | flecainide | 2.53e-05 | 71 | 111 | 5 | CID000003355 | |
| Drug | CAS 298-57-7 | 2.90e-05 | 73 | 111 | 5 | CID000002761 | |
| Drug | 1, 3-diallylurea | 3.10e-05 | 74 | 111 | 5 | CID000074537 | |
| Drug | ethosuximide | 3.10e-05 | 74 | 111 | 5 | CID000003291 | |
| Drug | tetralol | 3.11e-05 | 13 | 111 | 3 | CID000010747 | |
| Drug | GTP[S] | CACNA1B CACNA1S ADCY4 TPCN1 SCN3A ENTPD1 SCN4A SCN7A KCNK10 SCN10A CACNA1I CACNA1H | 3.19e-05 | 591 | 111 | 12 | CID000001764 |
| Drug | bupivacaine | 3.43e-05 | 125 | 111 | 6 | CID000002474 | |
| Drug | aprindine | 3.48e-05 | 38 | 111 | 4 | CID000002218 | |
| Drug | nisoldipine | 4.00e-05 | 78 | 111 | 5 | CID000004499 | |
| Drug | S-ropivacaine | 4.27e-05 | 40 | 111 | 4 | CID000071273 | |
| Drug | butamben | 4.92e-05 | 15 | 111 | 3 | CID000002482 | |
| Drug | pentasulfane | 6.03e-05 | 16 | 111 | 3 | CID000448216 | |
| Drug | Dibucaine | 7.04e-05 | 3 | 111 | 2 | DB00527 | |
| Drug | SureCN2398996 | 7.04e-05 | 3 | 111 | 2 | CID010220069 | |
| Drug | N-desmethylmethsuximide | 7.04e-05 | 3 | 111 | 2 | CID000092154 | |
| Drug | 1,3-dioxoisoindoline-5-carboxamide | 7.04e-05 | 3 | 111 | 2 | CID010679219 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 7.04e-05 | 3 | 111 | 2 | ctd:C561228 | |
| Drug | tetracaine | 7.14e-05 | 88 | 111 | 5 | CID000005411 | |
| Drug | isovalerate | 7.28e-05 | 143 | 111 | 6 | CID000010430 | |
| Drug | spiradoline | 7.46e-05 | 46 | 111 | 4 | CID000005620 | |
| Drug | KB-R7943 | 8.12e-05 | 47 | 111 | 4 | CID004534086 | |
| Drug | barium | 8.81e-05 | 148 | 111 | 6 | CID000104810 | |
| Drug | AC1NUZ8M | 8.83e-05 | 92 | 111 | 5 | CID000073211 | |
| Drug | Bay K 8644 | 9.48e-05 | 150 | 111 | 6 | CID000002303 | |
| Drug | indoxacarb | 9.57e-05 | 49 | 111 | 4 | CID000107720 | |
| Drug | manidipine | 1.03e-04 | 95 | 111 | 5 | CID000004008 | |
| Drug | KW-3049 | 1.04e-04 | 50 | 111 | 4 | CID000002324 | |
| Drug | glibenclamide | 1.08e-04 | 382 | 111 | 9 | CID000003488 | |
| Drug | nitrendipine | 1.19e-04 | 98 | 111 | 5 | CID000004507 | |
| Drug | AC1NSN3X | 1.40e-04 | 54 | 111 | 4 | CID005366189 | |
| Drug | Lidocaine | 1.40e-04 | 4 | 111 | 2 | DB00281 | |
| Drug | methsuximide | 1.40e-04 | 4 | 111 | 2 | CID000006476 | |
| Drug | 4-NA | 1.40e-04 | 4 | 111 | 2 | CID006102690 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 1.40e-04 | 4 | 111 | 2 | ctd:C501880 | |
| Drug | halothane | 1.54e-04 | 314 | 111 | 8 | CID000003562 | |
| Drug | loperamide | 1.65e-04 | 105 | 111 | 5 | CID000003954 | |
| Drug | triamterene | 1.85e-04 | 58 | 111 | 4 | CID000005546 | |
| Drug | IAA-94 | 2.25e-04 | 61 | 111 | 4 | CID000003667 | |
| Drug | AC1O7G5C | 2.33e-04 | 5 | 111 | 2 | CID006603942 | |
| Drug | phensuximide | 2.33e-04 | 5 | 111 | 2 | CID000006839 | |
| Drug | Flunarizine | 2.33e-04 | 5 | 111 | 2 | DB04841 | |
| Drug | 2-Methyl-4-chlorophenoxyacetic Acid | 2.33e-04 | 5 | 111 | 2 | ctd:D008456 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.85e-13 | 10 | 94 | 6 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.85e-13 | 10 | 94 | 6 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 8.09e-13 | 12 | 94 | 6 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | CACNA1B SLC24A3 KCNK18 SCN3A SCN4A SCN5A SCN7A SCN8A SCN10A ATP1B2 | 1.22e-10 | 163 | 94 | 10 | DOID:1826 (implicated_via_orthology) |
| Disease | HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1 | 1.00e-05 | 2 | 94 | 2 | 170400 | |
| Disease | Bartter disease type 4B | 1.00e-05 | 2 | 94 | 2 | cv:C4310805 | |
| Disease | Hypokalemic periodic paralysis, type 1 | 1.00e-05 | 2 | 94 | 2 | cv:C3714580 | |
| Disease | BARTTER SYNDROME, TYPE 4B | 1.00e-05 | 2 | 94 | 2 | C2751312 | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 1.00e-05 | 2 | 94 | 2 | C4310805 | |
| Disease | Bartter disease type 3 (implicated_via_orthology) | 1.00e-05 | 2 | 94 | 2 | DOID:0110144 (implicated_via_orthology) | |
| Disease | Bartter disease type 4b (is_implicated_in) | 1.00e-05 | 2 | 94 | 2 | DOID:0110146 (is_implicated_in) | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 1.00e-05 | 2 | 94 | 2 | 613090 | |
| Disease | Hypokalemic periodic paralysis | 1.00e-05 | 2 | 94 | 2 | cv:C0238358 | |
| Disease | Bartter disease (implicated_via_orthology) | 1.00e-05 | 2 | 94 | 2 | DOID:445 (implicated_via_orthology) | |
| Disease | Hypokalemic periodic paralysis type 1 | 3.01e-05 | 3 | 94 | 2 | C3714580 | |
| Disease | Brugada ECG Pattern | 6.00e-05 | 4 | 94 | 2 | C1721096 | |
| Disease | Hypokalemic periodic paralysis | 6.00e-05 | 4 | 94 | 2 | C0238358 | |
| Disease | thigh muscle volume | 1.49e-04 | 6 | 94 | 2 | EFO_0020107 | |
| Disease | Bartter syndrome | 1.49e-04 | 6 | 94 | 2 | cv:C0004775 | |
| Disease | heart function measurement | 1.74e-04 | 34 | 94 | 3 | EFO_0004311 | |
| Disease | electrocardiography, PR interval | 2.09e-04 | 7 | 94 | 2 | EFO_0004327, EFO_0004462 | |
| Disease | Colorectal Neoplasms | 2.64e-04 | 277 | 94 | 6 | C0009404 | |
| Disease | sickle cell anemia | 2.78e-04 | 8 | 94 | 2 | MONDO_0011382 | |
| Disease | hypokalemic periodic paralysis (implicated_via_orthology) | 2.78e-04 | 8 | 94 | 2 | DOID:14452 (implicated_via_orthology) | |
| Disease | supraventricular ectopy | 3.56e-04 | 9 | 94 | 2 | EFO_0009277 | |
| Disease | nephrogenic diabetes insipidus (implicated_via_orthology) | 4.44e-04 | 10 | 94 | 2 | DOID:12387 (implicated_via_orthology) | |
| Disease | Congenital myopathy (disorder) | 6.49e-04 | 12 | 94 | 2 | C0270960 | |
| Disease | Peripheral Nervous System Diseases | 6.90e-04 | 54 | 94 | 3 | C4721453 | |
| Disease | Brugada Syndrome 1 | 7.65e-04 | 13 | 94 | 2 | C4551804 | |
| Disease | T wave morphology measurement | 8.91e-04 | 14 | 94 | 2 | EFO_0008398 | |
| Disease | asymmetric dimethylarginine measurement | 8.91e-04 | 14 | 94 | 2 | EFO_0010463 | |
| Disease | P wave duration | 1.03e-03 | 15 | 94 | 2 | EFO_0005094 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 1.17e-03 | 16 | 94 | 2 | C0751885 | |
| Disease | Romano-Ward Syndrome | 1.17e-03 | 16 | 94 | 2 | C0035828 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 1.32e-03 | 17 | 94 | 2 | C0751883 | |
| Disease | plasma protease C1 inhibitor measurement | 1.32e-03 | 17 | 94 | 2 | EFO_0008261 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 1.66e-03 | 19 | 94 | 2 | C0751884 | |
| Disease | response to methotrexate, juvenile idiopathic arthritis | 1.66e-03 | 19 | 94 | 2 | EFO_0002609, GO_0031427 | |
| Disease | Brugada syndrome | 1.66e-03 | 19 | 94 | 2 | MONDO_0015263 | |
| Disease | inferior parietal cortex volume measurement | 1.66e-03 | 19 | 94 | 2 | EFO_0010307 | |
| Disease | cerebellum white matter volume change measurement, age at assessment | 1.84e-03 | 20 | 94 | 2 | EFO_0008007, EFO_0021498 | |
| Disease | alpha-tocopherol measurement | 1.84e-03 | 20 | 94 | 2 | EFO_0007898 | |
| Disease | Myasthenic Syndromes, Congenital | 2.65e-03 | 24 | 94 | 2 | C0751882 | |
| Disease | Brugada Syndrome (disorder) | 2.65e-03 | 24 | 94 | 2 | C1142166 | |
| Disease | psychosis predisposition measurement | 3.10e-03 | 26 | 94 | 2 | EFO_0008337 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ITLFFIRLLSYMFFH | 231 | Q8N6Q1 | |
| MLLLIFFYIFAVTGV | 246 | Q96P56 | |
| FLISTGNFMYLLFTT | 836 | Q96PZ7 | |
| VLTGFVMVFTLFLLY | 296 | Q8IUA7 | |
| LFFHLILSYFISTMI | 66 | Q49SQ1 | |
| GFMVIFILFFLYGLS | 296 | Q8N139 | |
| AASLVFFIYMISFIF | 1106 | Q8N139 | |
| MAVGLIVAFFILSYF | 91 | Q9NYM9 | |
| TLAMIAFFFIIIYLG | 76 | O95674 | |
| FTLYLIGFCMFVLSL | 171 | O95674 | |
| MGAISFFIFFFTLLV | 791 | Q8NFM4 | |
| FFAILMFAIIGLEFY | 231 | Q00975 | |
| KGMFSSFYFIVLTLF | 681 | Q00975 | |
| MRVLYLLFSFLFIFL | 1 | O15263 | |
| FIVFSLFFGSVTLMY | 246 | Q8NGY2 | |
| FIFLFLTYMLSVTGN | 26 | Q9NZP2 | |
| FLFFTLGIYDMTSVL | 81 | Q6TCH7 | |
| FLFGLFLSMYLVTVL | 26 | Q15622 | |
| FISLFIYMVLSLFIA | 501 | Q9GZU1 | |
| FFFMLITYLLSVSGN | 26 | A6NJZ3 | |
| MLAYLFFFSGTLLLN | 636 | Q96JH8 | |
| TAVALFFGALIFMYL | 246 | Q8NGQ6 | |
| SLFLMFLFIYLFTVL | 26 | Q8N0Y5 | |
| TAVALFFGTLIFMYL | 246 | Q8NGE9 | |
| VFFTLFLGMYLTTVL | 26 | Q8NGS2 | |
| LFGFFLLFYSLTLMG | 26 | Q8NGT7 | |
| LFFLIVYLVAFLGNM | 26 | Q8NGZ3 | |
| AVSLFFGTLIFMYLR | 246 | Q8NGQ5 | |
| FFLFFSIYIIVGMEI | 336 | Q7Z418 | |
| SFLISLMFLLSYLFG | 66 | Q13021 | |
| GFTMFLLYFVFLIIS | 1071 | O60721 | |
| MASVFHYFLLVLVFL | 1 | A6NDA9 | |
| LLFYLVFYGFLTAMF | 41 | P14415 | |
| YFMIPFFFTTLGLLY | 226 | Q9H3H5 | |
| SVFFLFMYISILFGN | 26 | Q9H339 | |
| TFGMDLFFIFLSYVL | 206 | Q9H344 | |
| LLFLFFSVFYVSSLM | 26 | Q8NGB9 | |
| MFFLYTDFFLSLVAV | 1 | P57789 | |
| HLLFFILFLTMYLFT | 26 | Q8NGQ2 | |
| VFFALFLGMYLTTVL | 26 | Q8NGS3 | |
| RIQMLLFGLFSLFYV | 21 | Q96R45 | |
| MFFYLTLAGAEVFLL | 106 | Q8NH03 | |
| TYVFLMVLFSLVLFT | 476 | P49961 | |
| FIFLFLTYMLSILGN | 26 | Q8NGE1 | |
| LLYGVFLCFSIMTEF | 616 | Q9HC58 | |
| TYMFLVSVIFFCLFL | 191 | Q5TF39 | |
| LFFVFYMLLTLHVSG | 196 | Q9NPH5 | |
| FLLLFFTYMLSITGN | 26 | A6NCV1 | |
| VFFTLFLGMYLITVL | 26 | Q8NGS1 | |
| LLFVFFLSMYLATVL | 26 | O43749 | |
| LLFVFFLSMYLATVL | 26 | Q96R84 | |
| RIQMLLFGLFSLFYV | 21 | O95047 | |
| LFATFFLLYAVTVMG | 26 | Q8NGU1 | |
| SEIQFILFGLFLSMY | 21 | O76099 | |
| ILFGLFLSMYLVTFT | 26 | O76099 | |
| FFFIMISYARIIGAV | 211 | Q8NGY6 | |
| AVVLIFFGSIIFMYV | 246 | Q8NGY6 | |
| YFFLGASEFLLLAVM | 106 | Q8NH40 | |
| TIVFLLVYFFGMASS | 316 | Q13467 | |
| IYLFIGTMFLLAGFV | 491 | Q9H461 | |
| VMAYGSLVFVLLFIF | 16 | Q9BWL3 | |
| MAIFFIIYIILIAFF | 1041 | Q13698 | |
| IYFILLIIVGSFFMI | 376 | Q9P0X4 | |
| FMLLFFIYAALGVEL | 1626 | Q9P0X4 | |
| TLSFIYIFIFVIGMI | 46 | P25106 | |
| YILSFIGMVIFTFTL | 406 | Q9Y5Y0 | |
| SGFLLVVFNFLLMAY | 56 | Q9C0D9 | |
| FFIPFLVILYSFMGI | 251 | Q9BZJ6 | |
| FIYFILLIIVGSFFM | 396 | O95180 | |
| MLLYFISFLLIVSFF | 1531 | O95180 | |
| FMLLFFIYAALGVEL | 1756 | O95180 | |
| FMLFLFIVGSYALVV | 246 | Q8NGC1 | |
| IFFSMILLVYIFTLT | 26 | Q8NGC8 | |
| IQIFLYLTMIGSEFF | 96 | Q8NH01 | |
| VLFFMFLFVYLITLG | 26 | P0C626 | |
| LFAIFFFFYLVTLMG | 26 | Q8NGT5 | |
| FFFYLVTLMGNTVII | 31 | Q8NGT5 | |
| LLFFGSVAVMYLRFS | 276 | Q8NGW6 | |
| MYFFLLFGDLESFLL | 101 | P30953 | |
| YMKAIGLFISFLSIF | 966 | P33527 | |
| LTMLLLAFVTSFFYL | 501 | Q8NHP6 | |
| SFIILFILYFIGMAI | 231 | Q9NYW0 | |
| LGIFSFFYTMAALVI | 121 | Q5VXT5 | |
| YIFFSILIMVLFVLG | 6 | P59544 | |
| LLALLSFAMLFISYF | 246 | P59551 | |
| SFAMLFISYFLSLVF | 251 | P59551 | |
| ELFTGFIKVLLYMAF | 216 | Q86TM6 | |
| GFLFQVIEMLIFAYF | 11 | O75445 | |
| FLVGMAVFAYSFIIL | 231 | Q7Z5M5 | |
| FITFMLLFAVSNGYL | 396 | Q14542 | |
| GLLLFLVMFIYSIFG | 1486 | P35499 | |
| ILGFIMFGLYFVFLV | 631 | Q9UI40 | |
| MFGLYFVFLVVSVLL | 636 | Q9UI40 | |
| LTAICLFFGTTLFMY | 296 | Q8NGC0 | |
| FLFGLFLSMYLVTVL | 26 | O76100 | |
| IFFMLVIFLGSFYLV | 391 | Q14524 | |
| GLLLFLVMFIYSIFG | 1661 | Q14524 | |
| YLYFSIVLFFGSMLV | 526 | Q9NY91 | |
| FLFGLFLSMYLVTVL | 26 | O14581 | |
| FIFGLFLSMYLVTVL | 26 | Q96RA2 | |
| LAFYVFMVFLATLGL | 11 | Q75T13 | |
| MIFFVLVIFLGSFYL | 401 | Q9NY46 | |
| FILMFVGIYLTFTVG | 311 | Q5PT55 | |
| FFFLFLAIYLFTLMG | 66 | Q8NGG2 | |
| LFAIFFFFYLVTLMG | 26 | Q8NGU2 | |
| FFFYLVTLMGNTVII | 31 | Q8NGU2 | |
| LSGFMVVFSLFLLYG | 296 | O94911 | |
| FTIFGTLAFFLVMKF | 396 | P51800 | |
| FTIFGTLAFFLVMKF | 396 | P51801 | |
| FFYMIILLLVFIVQF | 76 | O95857 | |
| LGNVVMYFAFLFLFT | 736 | Q9NZQ8 | |
| VLYFSIFSMFCLIGL | 186 | P49755 | |
| KIYMIFFVLVIFLGS | 371 | Q9Y5Y9 | |
| GLLLFLVMFIYSIFG | 1611 | Q9Y5Y9 | |
| KVITMFFNGFAIFLY | 676 | Q6ZQN7 | |
| LVFSLFFLISFIMYA | 326 | Q96J42 | |
| FFYMIILGLVFIFQF | 76 | Q12999 | |
| TYMIFFVLVIFVGSF | 386 | Q9UQD0 | |
| LTSLFMLFIFTYGLH | 431 | Q15904 | |
| YMFILSLSFLTVFIF | 211 | Q8IZN3 | |
| FFMIIFAILGFYLFS | 241 | Q9ULQ1 | |
| VVSFLFSFYMASLFL | 376 | Q01118 | |
| VVLFFSMISLYGQFR | 121 | Q9BSR8 | |
| MIVAYLVIFFNFLIF | 16 | Q9H0C3 | |
| QFLLFFLTAAYLMTG | 16 | Q658N2 | |
| VSIISFLFFTDMFIY | 121 | O75845 | |
| FLMLGLFLVNTIYFV | 56 | Q9NYW5 | |
| IIMGFFFYILITRLT | 326 | Q9NS93 |